
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939BE807DB0F4BC500002D7F9D09A5D6.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="plosone" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC10309994/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309994/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="PLOS ONE" /><meta name="citation_title" content="Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway" /><meta name="citation_author" content="Naoko Yamagishi" /><meta name="citation_author_institution" content="Department of Anatomy and Cell Biology, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan" /><meta name="citation_author" content="Yuta Yamamoto" /><meta name="citation_author_institution" content="Department of Anatomy and Cell Biology, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan" /><meta name="citation_author" content="Toshio Nishi" /><meta name="citation_author_institution" content="Department of Anatomy and Cell Biology, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan" /><meta name="citation_author" content="Takao Ito" /><meta name="citation_author_institution" content="Department of Anatomy and Cell Biology, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan" /><meta name="citation_author" content="Yoshimitsu Kanai" /><meta name="citation_author_institution" content="Department of Anatomy and Cell Biology, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan" /><meta name="citation_publication_date" content="2023" /><meta name="citation_issue" content="6" /><meta name="citation_volume" content="18" /><meta name="citation_doi" content="10.1371/journal.pone.0287788" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC10309994/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC10309994/" /><meta name="citation_pmid" content="37384717" /><meta name="DC.Title" content="Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="PLOS" /><meta name="DC.Contributor" content="Naoko Yamagishi" /><meta name="DC.Contributor" content="Yuta Yamamoto" /><meta name="DC.Contributor" content="Toshio Nishi" /><meta name="DC.Contributor" content="Takao Ito" /><meta name="DC.Contributor" content="Yoshimitsu Kanai" /><meta name="DC.Date" content="2023" /><meta name="DC.Identifier" content="10.1371/journal.pone.0287788" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway" /><meta property="og:type" content="article" /><meta property="og:description" content="Lansoprazole, a proton pump inhibitor, can exert antioxidant effects through the induction of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, independently of the inhibition of acid secretion in the gastrointestinal tract. Lansoprazole ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309994/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10309994/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22PLoS%20One%22[journal]" class="navlink">PLoS One</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10309994
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10309994/pdf/pone.0287788.pdf" class="int-view">PDF (2.3M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10309994/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10309994/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10309994" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10309994%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="X2YLHuY8I65Nk6DgSg5M9YTZR1Rf2OEOyqCOv8rQTY8jDPAhoFr3H4UfA84JTgyB">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10309994%2F&amp;text=Lansoprazole%20protects%20hepatic%20cells%20against%20cisplatin-induced%20oxidative%20stress%20through%20the%20p38%20MAPK%2FARE%2FNrf2%20pathway%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10309994%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309994/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10309994/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37384717/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10309994/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37384717/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10309994/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10309994/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22PLoS%20One%22[journal]" class="navlink">PLoS One</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10309994
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-plosone.png" alt="Logo of plosone" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://journals.plos.org/plosone/" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">PLoS One.</span> 2023; 18(6): e0287788. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 Jun 29. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1371%2Fjournal.pone.0287788" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0287788</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC10309994</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37384717">37384717</a></div></div></div><h1 class="content-title">Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yamagishi%20N%5BAuthor%5D" class="affpopup" co-rid="_co_idm140276979055728" co-class="co-affbox">Naoko Yamagishi</a>, <span class="fm-role">Conceptualization</span>, <span class="fm-role">Data curation</span>, <span class="fm-role">Formal analysis</span>, <span class="fm-role">Funding acquisition</span>, <span class="fm-role">Investigation</span>, <span class="fm-role">Methodology</span>, <span class="fm-role">Project administration</span>, <span class="fm-role">Resources</span>, <span class="fm-role">Software</span>, <span class="fm-role">Supervision</span>, <span class="fm-role">Validation</span>, <span class="fm-role">Visualization</span>, <span class="fm-role">Writing &#x02013; original draft</span>, <span class="fm-role">Writing &#x02013; review &#x00026; editing</span>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup></sup><sup>*</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yamamoto%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140276979033024" co-class="co-affbox">Yuta Yamamoto</a>, <span class="fm-role">Conceptualization</span>, <span class="fm-role">Methodology</span>, <span class="fm-role">Writing &#x02013; review &#x00026; editing</span>,<sup></sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Nishi%20T%5BAuthor%5D" class="affpopup" co-rid="_co_idm140276979029632" co-class="co-affbox">Toshio Nishi</a>, <span class="fm-role">Data curation</span>, <span class="fm-role">Methodology</span>, <span class="fm-role">Writing &#x02013; review &#x00026; editing</span>,<sup></sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ito%20T%5BAuthor%5D" class="affpopup" co-rid="_co_idm140276979026208" co-class="co-affbox">Takao Ito</a>, <span class="fm-role">Data curation</span>, <span class="fm-role">Writing &#x02013; review &#x00026; editing</span>,<sup></sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kanai%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140276979023280" co-class="co-affbox">Yoshimitsu Kanai</a>, <span class="fm-role">Data curation</span>, <span class="fm-role">Investigation</span>, <span class="fm-role">Supervision</span>, <span class="fm-role">Writing &#x02013; review &#x00026; editing</span><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140276979055728"><h3 class="no_margin">Naoko Yamagishi</h3><p>
Department of Anatomy and Cell Biology, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yamagishi%20N%5BAuthor%5D">Naoko Yamagishi</a></div></div><div id="_co_idm140276979033024"><h3 class="no_margin">Yuta Yamamoto</h3><p>
Department of Anatomy and Cell Biology, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yamamoto%20Y%5BAuthor%5D">Yuta Yamamoto</a></div></div><div id="_co_idm140276979029632"><h3 class="no_margin">Toshio Nishi</h3><p>
Department of Anatomy and Cell Biology, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Nishi%20T%5BAuthor%5D">Toshio Nishi</a></div></div><div id="_co_idm140276979026208"><h3 class="no_margin">Takao Ito</h3><p>
Department of Anatomy and Cell Biology, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ito%20T%5BAuthor%5D">Takao Ito</a></div></div><div id="_co_idm140276979023280"><h3 class="no_margin">Yoshimitsu Kanai</h3><p>
Department of Anatomy and Cell Biology, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kanai%20Y%5BAuthor%5D">Yoshimitsu Kanai</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Wei Hsum Yap, <span class="fm-role">Editor</span><sup></sup></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140276945176672_ai idm140276979055856_ai idm140276979006048_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140276945176672_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140276945176672_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140276945176672_ai" style="display:none"><div class="fm-affl" id="aff001">
Department of Anatomy and Cell Biology, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan
</div><div class="fm-affl" id="edit1">
Taylor&#x02019;s University, MALAYSIA
</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div id="coi001"><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</div><div id="cor001">* E-mail: <a href="mailto:dev@null" data-email="pj.ca.dem-amayakaw@n-gmy" class="oemail">pj.ca.dem-amayakaw@n-gmy</a></div></div><div class="fm-article-notes hide half_rhythm" id="idm140276945176672_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2023 Jan 4; Accepted 2023 Jun 13.</div></div><div class="permissions half_rhythm hide" id="idm140276945176672_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2023 Yamagishi et al</div><div class="license half_rhythm">This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="5" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>S1 Raw images: </strong>Original uncropped images underlying all blots. This file contains all uncropped blot information. The asterisk indicates a nonspecific protein band.<p>(PDF)</p></div><div><a href="/pmc/articles/PMC10309994/bin/pone.0287788.s001.pdf" data-ga-action="click_feat_suppl">pone.0287788.s001.pdf</a><span style="color:gray"> (3.5M)</span></div><div class="small guid">GUID: 4D76EE11-E514-40E4-9FDC-68E5FFE8AB8F</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>S1 Data: </strong>(XLSX)</div><div><a href="/pmc/articles/PMC10309994/bin/pone.0287788.s002.xlsx" data-ga-action="click_feat_suppl">pone.0287788.s002.xlsx</a><span style="color:gray"> (34K)</span></div><div class="small guid">GUID: 7A8A19E6-4365-4CDB-86A6-90A4F498F4A1</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Attachment: </strong>Submitted filename: <em class="submitted-filename">PONE-D-22-35612_reviewer report.docx</em></div><div><a href="/pmc/articles/PMC10309994/bin/pone.0287788.s003.docx" data-ga-action="click_feat_suppl">pone.0287788.s003.docx</a><span style="color:gray"> (19K)</span></div><div class="small guid">GUID: 7C733127-25BB-49C2-A792-6F93885C188E</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Attachment: </strong>Submitted filename: <em class="submitted-filename">Response to Reviewers.docx</em></div><div><a href="/pmc/articles/PMC10309994/bin/pone.0287788.s004.docx" data-ga-action="click_feat_suppl">pone.0287788.s004.docx</a><span style="color:gray"> (37K)</span></div><div class="small guid">GUID: 82BC4EA2-2A98-4678-A9E6-4E9C421CDD26</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Attachment: </strong>Submitted filename: <em class="submitted-filename">Response to Reviewers.docx</em></div><div><a href="/pmc/articles/PMC10309994/bin/pone.0287788.s005.docx" data-ga-action="click_feat_suppl">pone.0287788.s005.docx</a><span style="color:gray"> (41K)</span></div><div class="small guid">GUID: 1CAF54A2-AF30-4024-B28F-97E5DB756006</div></div></dd></dl><dl data-length="81" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p>All relevant data are within the manuscript and its <a href="#sec023" rid="sec023" class=" sec">Supporting information</a> files.</p></dd></dl></div><div id="abstract-a.r.b.r" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.r.b.rtitle">Abstract</h2><!--article-meta--><div><p class="p p-first-last">Lansoprazole, a proton pump inhibitor, can exert antioxidant effects through the induction of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, independently of the inhibition of acid secretion in the gastrointestinal tract. Lansoprazole has been reported to provide hepatoprotection in a drug-induced hepatitis animal model through the Nrf2/heme oxygenase-1 (HO1) pathway. We sought to investigate the molecular mechanism of cytoprotection by lansoprazole. An <em>in vitro</em> experimental model was conducted using cultured rat hepatic cells treated with lansoprazole to analyze the expression levels of Nrf2 and its downstream genes, the activity of Nrf2 using luciferase reporter assays, cisplatin-induced cytotoxicity, and signaling pathways involved in Nrf2 activation. Lansoprazole treatment of rat liver epithelial RL34 cells induced transactivation of Nrf2 and the expression of the Nrf2-dependent antioxidant genes encoding HO1, NAD(P)H quinone oxidoreductase-1, and glutathione S-transferase A2. Furthermore, cycloheximide chase experiments revealed that lansoprazole prolongs the half-life of the Nrf2 protein. Notably, cell viability was significantly increased by lansoprazole treatment in a cisplatin-induced cytotoxicity model. Moreover, the siRNA knockdown of Nrf2 fully abolished the cytoprotective effect of lansoprazole, whereas the inhibition of HO1 by tin-mesoporphyrin only partially abolished this. Finally, lansoprazole promoted the phosphorylation of p38 mitogen-activated protein kinase (MAPK) but not that of the extracellular signal-regulated kinase or the c-Jun N-terminal kinase. Using SB203580, a specific inhibitor for p38 MAPK, the lansoprazole-induced Nrf2/antioxidant response elements pathway activation and cytoprotective effects were shown to be exclusively p38 MAPK dependent. Lansoprazole was shown by these results to exert a cytoprotective effect on liver epithelial cells against the cisplatin-induced cytotoxicity through the p38 MAPK signaling pathway. This could have potential applications for the prevention and treatment of oxidative injury in the liver.</p></div></div><div id="sec001" class="tsec sec"><h2 class="head no_bottom_margin" id="sec001title">Introduction</h2><p class="p p-first">Nuclear factor-erythroid 2-related factor 2 (Nrf2) plays a crucial role in the transcriptional regulation of antioxidant and detoxifying genes in various cell types, including hepatocytes [<a href="#pone.0287788.ref001" rid="pone.0287788.ref001" class=" bibr popnode">1</a>, <a href="#pone.0287788.ref002" rid="pone.0287788.ref002" class=" bibr popnode">2</a>]. The activation of the Nrf2 pathway prevents liver injury caused by many hepatotoxicants [<a href="#pone.0287788.ref003" rid="pone.0287788.ref003" class=" bibr popnode">3</a>, <a href="#pone.0287788.ref004" rid="pone.0287788.ref004" class=" bibr popnode">4</a>]. Consequently, Nrf2 has recently been implicated as a new therapeutic target for the treatment of liver diseases. Under normal conditions, Nrf2 binds to a repressor Kelch-like ECH-associated protein 1 (Keap1) in the cytoplasm as an inactive complex. Keap1 functions as a substrate adaptor protein for a Cullin3-dependent E3 ubiquitin ligase complex and induces a rapid proteasomal degradation of Nrf2 [<a href="#pone.0287788.ref005" rid="pone.0287788.ref005" class=" bibr popnode">5</a>]. Keap1 contains several reactive cysteine residues that function as sensors for cellular oxidative stress [<a href="#pone.0287788.ref006" rid="pone.0287788.ref006" class=" bibr popnode">6</a>&#x02013;<a href="#pone.0287788.ref008" rid="pone.0287788.ref008" class=" bibr popnode">8</a>]. Modification of these critical cysteine residues of Keap1 by reactive oxygen species (ROS) inactivates the E3 ubiquitin ligase and stabilizes Nrf2, which subsequently accumulates and translocates into the nucleus. Nuclear Nrf2 binds to antioxidant response elements (AREs) that are located in the promoter region of genes and encode various antioxidant and phase 2 detoxifying enzymes such as heme oxygenase-1 (HO1), NAD(P)H quinone oxidoreductase-1 (NQO1), and glutathione S-transferase A2 (GSTA2) [<a href="#pone.0287788.ref009" rid="pone.0287788.ref009" class=" bibr popnode">9</a>&#x02013;<a href="#pone.0287788.ref011" rid="pone.0287788.ref011" class=" bibr popnode">11</a>]. The ARE-mediated upregulation of these enzymes facilitates the removal of toxic agents and ROS, thereby providing a protection against liver injury.</p><p>Exposure of cells to Nrf2 inducers, like oxidative stress stimuli, activates Nrf2/ARE-mediated response through different intracellular signaling pathways. Mitogen-activated protein kinase (MAPK) pathways are known to regulate Nrf2/ARE-driven gene expression [<a href="#pone.0287788.ref012" rid="pone.0287788.ref012" class=" bibr popnode">12</a>&#x02013;<a href="#pone.0287788.ref014" rid="pone.0287788.ref014" class=" bibr popnode">14</a>]. MAPKs are serine/threonine protein kinase that play a central role in the signaling cascade regulating cellular processes, such as cell proliferation, differentiation, and apoptosis. Three major MAPK subfamilies have been extensively studied: extracellular signal-regulated kinases (ERKs), c-Jun N-terminal kinases (JNKs), and p38 MAPK. Each kinase establishes, in principle, parallel and independent signaling pathways. Depending on the cellular and stimulatory context, there is often significant cross-talk between each of the kinases because they can respond to common upstream activators and phosphorylate common downstream targets. Alam <em>et al</em>. reported that cadmium-induced HO1 gene expression requires the sequential activation of the p38 MAPK pathway and Nrf2 in human breast cancer MCF-7 cells [<a href="#pone.0287788.ref012" rid="pone.0287788.ref012" class=" bibr popnode">12</a>]. In contrast, in human hepatoblastoma HepG2 cells, JNK activated the induction of Nrf2/ARE-mediated gene expression by the overexpression of common upstream kinases, whereas p38 MAPK showed the opposite effects [<a href="#pone.0287788.ref013" rid="pone.0287788.ref013" class=" bibr popnode">13</a>]. Additionally, exposure of HepG2 cells to the chemical pyrrolidine dithiocarbamate, the activation of both ERK1/2 and p38 MAPK are required for induction of the ARE-mediated &#x003b3;-glutamylcysteine synthetase subunit genes [<a href="#pone.0287788.ref014" rid="pone.0287788.ref014" class=" bibr popnode">14</a>]. Based on these observations, the capability of lansoprazole to upregulate expression of antioxidant genes via the MAPK/ARE/Nrf2 pathway was investigated using rat hepatic cells.</p><p>Cisplatin is a chemotherapeutic agent commonly used to treat various solid tumors. Cisplatin-induced cytotoxicity has been described as a function of DNA crosslinking, followed by formation of DNA lesions. Cisplatin has been recently shown to significantly increase the generation of ROS that can cause organ toxicity, including hepatotoxicity [<a href="#pone.0287788.ref015" rid="pone.0287788.ref015" class=" bibr popnode">15</a>&#x02013;<a href="#pone.0287788.ref018" rid="pone.0287788.ref018" class=" bibr popnode">18</a>]. Oxidative stress is the one of the most important mechanisms involved in cisplatin toxicity.</p><p class="p p-last">Lansoprazole is a potent proton pump inhibitor that is often used to treat acid-related disorders, including gastric and duodenal ulcers, gastro-esophageal reflux disease, and nonulcer dyspepsia. It strongly reduces the secretion of gastric acid by blocking H<sup>+</sup>/K<sup>+</sup>-ATPase in gastric parietal cells. In addition, it exerts anti-inflammatory and antioxidant effects against necrotizing agent-induced gastric lesions through a mechanism that acts independently of inhibition of acid secretion [<a href="#pone.0287788.ref019" rid="pone.0287788.ref019" class=" bibr popnode">19</a>&#x02013;<a href="#pone.0287788.ref022" rid="pone.0287788.ref022" class=" bibr popnode">22</a>]. Several studies have demonstrated a lansoprazole-induced expression of the antioxidant protein HO1 in gastric epithelial cells [<a href="#pone.0287788.ref023" rid="pone.0287788.ref023" class=" bibr popnode">23</a>, <a href="#pone.0287788.ref024" rid="pone.0287788.ref024" class=" bibr popnode">24</a>], endothelial cells [<a href="#pone.0287788.ref025" rid="pone.0287788.ref025" class=" bibr popnode">25</a>], and neutrophils [<a href="#pone.0287788.ref026" rid="pone.0287788.ref026" class=" bibr popnode">26</a>] as well as in the small intestines of rats [<a href="#pone.0287788.ref027" rid="pone.0287788.ref027" class=" bibr popnode">27</a>&#x02013;<a href="#pone.0287788.ref029" rid="pone.0287788.ref029" class=" bibr popnode">29</a>], thereby protecting these cells from oxidative stress. HO1 is a stress-inducible protein, and its reaction products from heme degradation have been linked to cytoprotection. Takagi <em>et al</em>. proposed that the induction of HO1 by lansoprazole can occur by Nrf2 activation in rat gastric mucosal cells [<a href="#pone.0287788.ref023" rid="pone.0287788.ref023" class=" bibr popnode">23</a>]. The induction of HO1 both in the gastrointestinal mucosa and in the liver can have antioxidant and anti-inflammatory properties [<a href="#pone.0287788.ref030" rid="pone.0287788.ref030" class=" bibr popnode">30</a>, <a href="#pone.0287788.ref031" rid="pone.0287788.ref031" class=" bibr popnode">31</a>]. We previously reported that lansoprazole attenuates the drug-induced oxidative liver injury in rats through the Nrf2/HO1 pathway [<a href="#pone.0287788.ref032" rid="pone.0287788.ref032" class=" bibr popnode">32</a>]. Furthermore, lansoprazole treatment can suppress the expression of proinflammatory cytokines and the progression of hepatic fibrogenesis induced by a choline-deficient L-amino acid-defined diet [<a href="#pone.0287788.ref033" rid="pone.0287788.ref033" class=" bibr popnode">33</a>]. However, how lansoprazole activates the Nrf2 pathway in hepatic cells remains unclear. Here, we focus on the role of the Nrf2 pathway to provide further insight into our previous findings on the molecular mechanisms of lansoprazole-mediated hepatoprotection. The present study comprises an <em>in vitro</em> experimental model that simulates the cisplatin-induced oxidative stress in rat hepatic cells.</p></div><div id="sec002" class="tsec sec"><h2 class="head no_bottom_margin" id="sec002title">Materials and methods</h2><div id="sec003" class="sec sec-first"><h3 id="sec003title">Chemicals and reagents</h3><p class="p p-first-last">Lansoprazole was purchased from the Tokyo Chemical Industry Co. (Tokyo, Japan). p38 MAPK inhibitor SB203580 and protein biosynthesis inhibitor cycloheximide (CHX) were purchased from the FUJIFILM Wako Pure Chemical Co. (Osaka, Japan). Cisplatin was purchased from Nichi-Iko Pharmaceutical Co. (Toyama, Japan). The specific HO1 inhibitor tin-mesoporphyrin IX (SnMP) was purchased from BIOMOL Research Inc. (Plymouth Meeting, PA, USA).</p></div><div id="sec004" class="sec"><h3 id="sec004title">Cell culturing, transfection, and treatment</h3><p class="p p-first-last">The untransformed rat hepatic cell line RL34 was obtained from the Japanese Collection of Research Bioresources Bank (JCRB0247). Cells were maintained in Dulbecco&#x02019;s modified Eagle medium (DMEM) without phenol red (FUJIFILM Wako Pure Chemical Co., Osaka, Japan) and supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS) (Sigma-Aldrich, St. Louis, MO, USA), at 37&#x000b0;C with 5% CO<sub>2</sub>. Plasmid transfection was performed using jetPRIME transfection regent (Polyplus-transfection S.A., Illkirch, France). Lansoprazole was dissolved in dimethyl sulfoxide (DMSO) (FUJIFILM Wako Pure Chemical Co.). Cells were treated with 100 &#x003bc;M of lansoprazole; as a vehicle control, an identical amount of DMSO was added to the media.</p></div><div id="sec005" class="sec"><h3 id="sec005title">Cell viability assay</h3><p class="p p-first-last">The cell viability assay was performed by using the Cell Titer 96 Aqueous One Solution Cell Proliferation Assay (Promega Corp., Madison, WI, USA). Cells were plated in a 96-well flat-bottom plate and cultured in 100 &#x003bc;L of DMEM containing 10% FBS. Cells were pretreated with 100 &#x003bc;M of lansoprazole for 3 h and were then treated with 20 &#x003bc;M of cisplatin. After 24 h, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) reagent (20 &#x003bc;L/well) (Promega Corp.) was added to each well, and cells were incubated for a further 1 h at 37&#x000b0;C. The absorbance was recorded at 490 nm in a 96-well plate reader (Corona Electric Co., Ltd., Ibaraki, Japan). Data for cell viability represent the results of at least three independent experiments, each of which was performed in triplicate.</p></div><div id="sec006" class="sec"><h3 id="sec006title">Subcellular fractionation and immunoblots</h3><p class="p p-first-last">Nuclear and cytoplasmic fractions were prepared by using a nuclear/cytosol fractionation kit (BioVision Inc., Mountain View, CA, USA). Briefly, cells were harvested with cold phosphate-buffered saline (PBS). Cells were then lysed in 400 &#x003bc;L of the extraction buffer containing dithiothreitol and a protease inhibitor cocktail (Roche, Mannheim, Germany), on ice, for 30 min. After 10 min of centrifugation (700 &#x000d7; g), the supernatant (cytosolic fraction) was collected, and the pellet was resuspended in a nuclear extraction buffer to obtain the nuclear fraction. Whole cell extracts were prepared with a RIPA buffer (50 mM Tris-HCl pH 7.6, 150 mM of NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS) (Nacalai Tesque, Inc., Kyoto, Japan) with a protease inhibitor cocktail (Roche). The protein concentration was determined using a BCA protein assay kit (Takara Bio, Inc., Shiga, Japan). Cell lysates (30 &#x003bc;g protein/lane) were resolved using 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and separated proteins were transferred to a polyvinylidene difluoride membrane (Merck Millipore, Bedford, MA, USA). After blocking with 5% nonfat dry milk for 1 h at room temperature, the membrane was incubated overnight at 4&#x000b0;C with a primary antibody. The following primary antibodies were used: anti-Nrf2 antibody (1:5,000, 16396-1-AP; Proteintech Group, Inc., Rosemont, IL, USA), anti-Histone H3 antibody (1:1,000, ab1791; Abcam, Cambridge UK), anti-&#x003b1;-tubulin antibody (1:1000, sc-23948; Santa Cruz Biotechnology), anti-&#x003b2;-actin antibody (1&#x02236;500, A5060; Sigma-Aldrich), anti-HO1 antibody (1&#x02236;3,000, SPA-895; Enzo Life Sciences, Inc., Farmingdale, New York, USA), anti-p38&#x003b1;/&#x003b2; (A-12) antibody (1:1,000, sc-7972; Santa Cruz Biotechnology), anti-phospho-p38 antibody (1:1,000, no. 9211; Cell Signaling Technology, Inc., Danvers, MA, USA), anti-ERK1/2 antibody (1:1,000, no. 4695; Cell Signaling Technology, Inc.), anti-phospho-ERK1/2 antibody (1:1,000, no. 9101; Cell Signaling Technology, Inc.), anti-JNK antibody (1:1,000, no. 9252; Cell Signaling Technology, Inc.), and anti-phospho-JNK antibody (1:1,000, no. 9251; Cell Signaling Technology, Inc.). Following incubation with an appropriate secondary antibody for 1 h at room temperature, the bound antibodies were detected using a Western BLoT Hyper HRP Substrate (Takara Bio, Inc.). Three independent experiments were performed, and representative immunoblot analysis of the experiment is presented below.</p></div><div id="sec007" class="sec"><h3 id="sec007title">Cycloheximide chase assay</h3><p class="p p-first-last">Cells were treated with 100 &#x003bc;M of lansoprazole for 3 h followed by incubation with 10 &#x003bc;M of CHX. Cell lysates were prepared 0, 15, 30, 45, 60, and 75 min after the CHX treatment. Whole cell extracts (10 &#x003bc;g) were resolved using SDS-PAGE and were analyzed by immunoblotting with an anti-Nrf2 antibody (Proteintech Group, Inc.); an anti-&#x003b2;-actin antibody (Sigma-Aldrich) was used as a loading control. The degradation rate of the Nrf2 protein was quantified by a densitometric measurement of the immunoblot intensity with ImageJ ver. 1.53v 21 (U.S. National Institutes of Health, Bethesda, Maryland, USA). Data represent the results of three independent experiments, each of which was performed in triplicate.</p></div><div id="sec008" class="sec"><h3 id="sec008title">&#x003bb; protein phosphatase (&#x003bb;PPase) assay</h3><p class="p p-first-last">For dephosphorylation reactions, the nuclear extracts obtained from lansoprazole-treated cells were prepared as described above. Extracts were incubated with &#x003bb;PPase (New England BioLabs Japan Inc., Tokyo, Japan) at 8 units of enzyme/&#x003bc;g of protein extract diluted in 1&#x000d7;NEBuffer (50 mM of HEPES, 100 mM of NaCl, 2 mM of DTT, and 0.01% Brij 35 at pH 7.5) and 1 mM of MnCl<sub>2</sub> at 30&#x000b0;C, for 30 min. Following incubation, samples were analyzed by immunoblotting. Three independent experiments were performed, and representative immunoblot analysis of the experiment is presented below.</p></div><div id="sec009" class="sec"><h3 id="sec009title">RNA extraction and quantitative RT-PCR</h3><p class="p p-first">Total RNA was isolated from cultured cells using Sepasol reagent (Nacalai Tesque, Inc.). For all samples, 200 ng total RNA was used to make cDNA. First strand cDNA was synthesized with the use of the ReverTra Ace qPCR RT Kit (Toyobo, Osaka, Japan) following the manufacturer&#x02019;s instructions in a final volume of 20 &#x003bc;l. The obtained cDNA fragments were diluted 10-fold with water to 1 ng/&#x003bc;l. Quantitative RT-PCR analyses were performed using the Brilliant III Ultra-Fast SYBR Green QPCR Master Mix (Agilent Technologies Inc., Tokyo, Japan) and the AriaMX Real-time PCR system (Agilent Technologies Inc.). Each reaction contained 2.5 &#x003bc;L diluted cDNA (2.5 ng/reaction), 200 nM of each primer, and 1 &#x000d7; SYBR Green Master Mix, in a final volume of 10 &#x003bc;L. All reactions were performed in duplicate per cDNA sample. As a control for genomic DNA contamination, total RNA without reverse transcription was tested for each sample per gene. A no-template control was included in each run per gene. The thermal profile of the reaction was 95&#x000b0;C for 5 min activation and denaturation, followed by 40 cycles of 95&#x000b0;C for 10 sec, and 60&#x000b0;C for 10 sec. Finally, a melting curve was generated by increasing the temperature starting from 65&#x000b0;C to 95&#x000b0;C to determine the specificity of the reactions. The quantification cycle number (Cq) was determined per reaction with Agilent AriaMx version 2.0. The primers used are listed in <a href="/pmc/articles/PMC10309994/table/pone.0287788.t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone.0287788.t001" rid-ob="ob-pone.0287788.t001" co-legend-rid=""><span>Table 1</span></a>. The relative standard curve method was used to calculate the relative mRNA expression. mRNA expression levels were normalized to those of <em>&#x003b2;-actin</em> and glyceraldehyde-triphosphate dehydrogenase (<em>GAPDH</em>) mRNA. Data represent the results of three independent experiments, each of which was performed in triplicate.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="pone.0287788.t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>The primer sequences used for quantitative RT-PCR.</strong></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" rowspan="1" colspan="1">Gene</th><th align="center" rowspan="1" colspan="1">Primer</th><th align="center" rowspan="1" colspan="1">Sequence (5&#x002b9;&#x02013;3&#x002b9;)</th></tr></thead><tbody><tr><td align="center" rowspan="2" colspan="1"><em>HO1</em> (rat)</td><td align="center" rowspan="1" colspan="1">Forward</td><td align="center" rowspan="1" colspan="1">
<kbd>ACAGGGTGACAGAAGAGGCTAA</kbd>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Reverse</td><td align="center" rowspan="1" colspan="1">
<kbd>CTGTGAGGGACTCTGGTCTTTG</kbd>
</td></tr><tr><td align="center" rowspan="2" colspan="1"><em>NQO1</em> (rat)</td><td align="center" rowspan="1" colspan="1">Forward</td><td align="center" rowspan="1" colspan="1">
<kbd>CAGCGGCTCCATGTACT</kbd>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Reverse</td><td align="center" rowspan="1" colspan="1">
<kbd>GACCTGGAAGCCACAGAAG</kbd>
</td></tr><tr><td align="center" rowspan="2" colspan="1"><em>GSTA2</em> (rat)</td><td align="center" rowspan="1" colspan="1">Forward</td><td align="center" rowspan="1" colspan="1">
<kbd>CTTCTCCTCTATGTTGAAGAGTTTG</kbd>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Reverse</td><td align="center" rowspan="1" colspan="1">
<kbd>TTTTGCATCCACGGGAA</kbd>
</td></tr><tr><td align="center" rowspan="2" colspan="1"><em>&#x003b2;-actin</em> (rat)</td><td align="center" rowspan="1" colspan="1">Forward</td><td align="center" rowspan="1" colspan="1">
<kbd>GGAGATTACTGCCCTGGCTCCTA</kbd>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Reverse</td><td align="center" rowspan="1" colspan="1">
<kbd>GACTCATCGTACTCCTGCTTGCTG</kbd>
</td></tr><tr><td align="center" rowspan="2" colspan="1"><em>GAPDH</em> (rat)</td><td align="center" rowspan="1" colspan="1">Forward</td><td align="center" rowspan="1" colspan="1">
<kbd>AGGTTGTCTCCTGTGACTTC</kbd>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Reverse</td><td align="center" rowspan="1" colspan="1">
<kbd>CTGTTGCTGTAGCCATATTC</kbd>
</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140276978923264"><a target="object" rel="noopener" href="/pmc/articles/PMC10309994/table/pone.0287788.t001/?report=objectonly">Open in a separate window</a></div></div></div><div id="sec010" class="sec"><h3 id="sec010title">siRNA transfection</h3><p class="p p-first-last">Two stealth siRNA duplexes targeting the rat Nrf2 mRNA (#1: <kbd>5'-UGG AGC AAG ACU UGG GCC ACU UAA A-3'</kbd>; #2: <kbd>5'-GGA AAC CUU ACU CUC CCA GUG AGU A-3'</kbd>) and the stealth RNAi-negative control siRNA (medium GC content) were purchased from Thermo Fisher Scientific, Inc. (Waltham, MA, USA). Cells were transfected with siRNA (5 nM) using Lipofectamine RNAiMax and Opti-MEM media (Thermo Fisher Scientific, Inc., Waltham, MA, USA) according to the manufacturer&#x02019;s instructions. Data represent the results of three independent experiments, each of which was performed in triplicate.</p></div><div id="sec011" class="sec"><h3 id="sec011title">Generation of a stable ARE-driven reporter system</h3><p class="p p-first-last">The ARE-driven reporter gene construct pGL4.37 [luc2P/ARE/Hygro] was purchased from Promega Corp (Madison, WI, USA). RL34 cells were transfected with the pGL4.37 plasmid using jetPRIME transfection reagent. After incubation with growth media for 48 h, cells were cultured with media containing 400 &#x003bc;g/mL of hygromycin B (Sigma-Aldrich, St. Louis, MO, USA) for 3 weeks in order to establish a stable cell line. Hygromycin B-resistant colonies were pooled and used for the reporter gene analysis. Stable transfectants were maintained in DMEM supplemented with 10% FBS and 80 &#x003bc;g/mL hygromycin B at 37&#x000b0;C, with 5% CO<sub>2</sub>.</p></div><div id="sec012" class="sec"><h3 id="sec012title">Measurement of ARE-dependent transcriptional activity</h3><p class="p p-first-last">Cells stably transfected with an ARE-reporter were replated in 12-well plates and exposed to 100 &#x003bc;M of lansoprazole for 3 h. Luciferase activities in cell lysates were measured using the luciferase assay system (Promega Corp.). Data represent the results of at least three independent experiments, each of which was performed in triplicate.</p></div><div id="sec013" class="sec"><h3 id="sec013title">Immunocytochemistry</h3><p class="p p-first-last">Cells were grown on glass bottom dishes (MatTek Corporation, Ashland, MA, USA) and exposed to 100 &#x003bc;M of lansoprazole for 3 h. Cells were then washed with PBS and fixed in 4% (w/v) paraformaldehyde (PFA) in phosphate buffer, at room temperature. Fixed cells were then permeabilized in 0.1% Triton X-100. After blocking with 1% bovine serum albumin for 30 min at room temperature, cells were incubated with an anti-Nrf2 (H-300) antibody (1:50, sc-13032; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) overnight, at 4&#x000b0;C. Following three washes in PBS, an Alexa Fluor 488 goat anti-rabbit IgG antibody (1:250; Thermo Fisher Scientific, Inc., Waltham, MA, USA) was added for 2 h, at room temperature. Finally, cells were stained with Hoechst 33342 dye (Dojindo Laboratories, Kumamoto, Japan). Images were obtained using a confocal microscope (Carl Zeiss Japan, LSM 700 ZEN, Tokyo, Japan). Three independent experiments were performed, and representative immunocytochemical analysis of the experiment is shown.</p></div><div id="sec014" class="sec sec-last"><h3 id="sec014title">Statistical analysis</h3><p class="p p-first-last">All statistical analyses were performed using JMP version 14.3 statistical software (SAS Institute Inc., Cary, NC, USA). Results are expressed as mean &#x000b1; standard deviation (SD). Statistical analyses were performed using an unpaired Student&#x02019;s <em>t</em>-test. For multiple comparisons, we performed one-way analysis of variance (ANOVA) followed by Tukey&#x02019;s multiple comparison <em>post hoc</em> test. Values of <em>p</em> that were found to be &#x0003c;0.05 were considered to be statistically significant.</p></div></div><div id="sec015" class="tsec sec"><h2 class="head no_bottom_margin" id="sec015title">Results</h2><div id="sec016" class="sec sec-first"><h3 id="sec016title">Lansoprazole activates the Nrf2/ARE pathway in RL34 cells</h3><p class="p p-first">A series of experiments using RL34 cells, a rat hepatic cell line was designed to investigate the molecular mechanism underlying the activation of the Nrf2 pathway. We first examined whether lansoprazole could activate the Nrf2/ARE pathway in this cell line. Immunoblotting studies confirmed the significant increases in Nrf2 levels in both the nuclear (41-fold) and the cytoplasmic (3-fold) fractions of the lansoprazole-treated cells (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g001" rid-ob="ob-pone.0287788.g001" co-legend-rid="lgnd_pone.0287788.g001"><span>Fig 1A</span></a>). Subsequently, to confirm the nuclear localization of the Nrf2 protein following treatment with lansoprazole, immunocytochemistry with an anti-Nrf2 antibody was performed. Nrf2 exhibited weak cytoplasmic staining in the control (DMSO-treated) cells, whereas the lansoprazole-treated cells exhibited strong nuclear Nrf2 staining (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g001" rid-ob="ob-pone.0287788.g001" co-legend-rid="lgnd_pone.0287788.g001"><span>Fig 1B</span></a>). Furthermore, the mRNA levels of the Nrf2 target genes encoding <em>HO1</em>, <em>NQO1</em>, and <em>GSTA2</em> were increased by 17-, 12- and 33-times, respectively, when compared with those of the DMSO-treated cells in the results using <em>&#x003b2;-actin</em> as a reference (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g001" rid-ob="ob-pone.0287788.g001" co-legend-rid="lgnd_pone.0287788.g001"><span>Fig 1C</span></a>). Similar results were obtained when using <em>GAPDH</em> as a reference gene (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g001" rid-ob="ob-pone.0287788.g001" co-legend-rid="lgnd_pone.0287788.g001"><span>Fig 1D</span></a>). Two clonal RL34 cell lines stably expressing an ARE-driven luciferase reporter (clones #1 and #2) were then established to analyze the transcriptional activity of the ARE promoter. These cells exhibited 20- and 30-fold induction of their luciferase activity following treatment with lansoprazole for 3 h (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g001" rid-ob="ob-pone.0287788.g001" co-legend-rid="lgnd_pone.0287788.g001"><span>Fig 1E</span></a>). Lansoprazole is suggested by these results to induce the Nrf2 nuclear accumulation, and subsequently enhance the expression of antioxidant genes in RL34 cells. Nrf2 activators are recognized to increase the stability of the Nrf2 protein by inhibiting the proteasomal degradation of Keap1 [<a href="#pone.0287788.ref034" rid="pone.0287788.ref034" class=" bibr popnode">34</a>, <a href="#pone.0287788.ref035" rid="pone.0287788.ref035" class=" bibr popnode">35</a>]. The effect of lansoprazole on the degradation rate of the Nrf2 protein was therefore determined using a CHX chase assay. Treatment with lansoprazole extended the half-life of the Nrf2 protein from 33.0 to 61.5 min (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g001" rid-ob="ob-pone.0287788.g001" co-legend-rid="lgnd_pone.0287788.g001"><span>Fig 1F</span></a>). Lansoprazole is indicated to inhibit the degradation of the Nrf2 protein, and increases its stability.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone.0287788.g001" co-legend-rid="lgnd_pone.0287788.g001"><a href="/pmc/articles/PMC10309994/figure/pone.0287788.g001/" target="figure" rid-figpopup="pone.0287788.g001" rid-ob="ob-pone.0287788.g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140276978847952"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10309994_pone.0287788.g001.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0287788.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10309994/bin/pone.0287788.g001.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140276978847952"><a target="object" rel="noopener" href="/pmc/articles/PMC10309994/figure/pone.0287788.g001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone.0287788.g001"><div><a class="figpopup" href="/pmc/articles/PMC10309994/figure/pone.0287788.g001/" target="figure" rid-figpopup="pone.0287788.g001" rid-ob="ob-pone.0287788.g001">Fig 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Lansoprazole activates the Nrf2/ARE pathway in RL34 cells.</strong><p>A: Representative immunoblot for Nrf2 expression levels in the nuclear and cytoplasmic protein lysates obtained from cells treated with 100 &#x003bc;M of lansoprazole for 3 h; &#x003b1;-tubulin and histone H1 were loading controls for the cytoplasmic and nuclear lysates, respectively (left). Densitometric quantification of the representative immunoblots was performed using ImageJ, and values were normalized to each of the loading control protein level (right). B: Representative immunocytochemical images of the subcellular localization of Nrf2. RL34 cells were treated with 100 &#x003bc;M of lansoprazole for 3 h. Cells were fixed in 4% PFA for 15 min, followed by staining with an anti-Nrf2 antibody and an Alexa Fluor 488-conjugated goat anti-rabbit IgG antibody. Counterstaining of the nuclei was performed with Hoechst 33342. The scale bar represents 50 &#x003bc;m. C and D: Relative mRNA expression levels of Nrf2-induced genes <em>HO1</em>, <em>NQO1</em>, and <em>GSTA2</em> in cells treated with 100 &#x003bc;M lansoprazole for 3 h. RNA levels were normalized to those of <em>&#x003b2;-actin</em> (C) or <em>GAPDH</em> (D). E: Induction of the ARE-dependent luciferase reporter activity by lansoprazole. RL34 cells stably expressing an ARE-reporter gene were treated with 100 &#x003bc;M of lansoprazole for 3 h, and the luciferase activity in the cell lysates was measured. F: Degradation rate of the Nrf2 protein after CHX chase. Cells were treated with 100 &#x003bc;M of lansoprazole for 3 h and were then treated with 10 &#x003bc;M of CHX for the indicated periods. Cell lysates were used for immunoblotting analysis with an anti-Nrf2 and anti-&#x003b2;-actin antibody. Intensities of the Nrf2 bands were quantified and plotted on a semilog graph to obtain half-life values. Abbreviations used in the figure: LPZ, lansoprazole; CHX, cycloheximide. Data represent the mean &#x000b1; SD of the three independent experiments performed in triplicate. Statistical analysis was performed by using Student&#x02019;s <em>t</em>-test. *: <em>p</em> &#x0003c; 0.05 <em>vs</em>. DMSO-treated cells.</p></div></div></div></div><div id="sec017" class="sec"><h3 id="sec017title">Lansoprazole suppresses the cisplatin-induced cytotoxicity; activity is partially dependent upon HO1</h3><p class="p p-first">An <em>in vitro</em> cisplatin-induced cytotoxicity model was conducted to assess the effect of lansoprazole on oxidative stress-induced cell death. Cisplatin cytotoxicity was determined using an MTS assay. Cell viability was decreased to 25% by cisplatin treatment when compared with that of untreated cells, whereas cells pretreated with lansoprazole exhibited an increase in their cell viability of approximately 80% (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g002" rid-ob="ob-pone.0287788.g002" co-legend-rid="lgnd_pone.0287788.g002"><span>Fig 2</span></a>). The effect of lansoprazole was partially eliminated by co-treatment with the specific HO1 inhibitor tin-mesoporphyrin IX (SnMP). Lansoprazole is suggested by these results to have a protective effect against the cisplatin-induced cytotoxicity and this effect is partially mediated by the upregulation of HO1.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone.0287788.g002" co-legend-rid="lgnd_pone.0287788.g002"><a href="/pmc/articles/PMC10309994/figure/pone.0287788.g002/" target="figure" rid-figpopup="pone.0287788.g002" rid-ob="ob-pone.0287788.g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140276978840064"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10309994_pone.0287788.g002.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0287788.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10309994/bin/pone.0287788.g002.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140276978840064"><a target="object" rel="noopener" href="/pmc/articles/PMC10309994/figure/pone.0287788.g002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone.0287788.g002"><div><a class="figpopup" href="/pmc/articles/PMC10309994/figure/pone.0287788.g002/" target="figure" rid-figpopup="pone.0287788.g002" rid-ob="ob-pone.0287788.g002">Fig 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Lansoprazole suppresses the cisplatin-induced cytotoxicity.</strong><p>Cell viability of cisplatin-treated cells exposed to a lansoprazole pretreatment. RL34 cells were pretreated with 100 &#x003bc;M of lansoprazole for 3 h and then exposed to 20 &#x003bc;M of cisplatin for an additional 24 h. HO1 inhibitor SnMP was administered simultaneously with lansoprazole. Cell viability was quantified using an MTS assay. Data are expressed as a percentage of viability when compared with the viability of the DMSO-treated cells. Data represent the mean &#x000b1; SD of three independent experiments performed in triplicate. Statistical analysis was performed by using ANOVA followed by Tukey&#x02019;s test for multiple comparisons. *: <em>p</em> &#x0003c; 0.01. Abbreviations: LPZ, lansoprazole; SnMP, tin-mesoporphyrin IX; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium,inner salt.</p></div></div></div></div><div id="sec018" class="sec"><h3 id="sec018title">Nrf2 is necessary for the cytoprotective activity of lansoprazole</h3><p class="p p-first">To demonstrate whether the induction of expression of HO1 by lansoprazole is dependent upon that of Nrf2, an siRNA-mediated silencing of Nrf2 was performed. RL34 cells were transfected with one of two siRNAs targeting different sites in the rat <em>Nrf2</em> mRNA (siNrf2#1 and siNrf2#2). After 24 h, the <em>Nrf2</em> mRNA levels were examined by quantitative RT-PCR. The knockdown efficiencies of the individual siRNAs on the Nrf2 expression were 91% (siNrf2#1) and 91.4% (siNrf2#2) as compared with the expression levels of cells treated with the control siRNA in the results using <em>&#x003b2;-actin</em> as a reference (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g003" rid-ob="ob-pone.0287788.g003" co-legend-rid="lgnd_pone.0287788.g003"><span>Fig 3A</span></a>). Similar results were obtained when using GAPDH as a reference gene (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g003" rid-ob="ob-pone.0287788.g003" co-legend-rid="lgnd_pone.0287788.g003"><span>Fig 3B</span></a>). RL34 cells were transfected with pooled Nrf2 siRNAs, and the expression level of lansoprazole-induced HO1 were assessed. As expected, the Nrf2 knockdown completely blocked the lansoprazole-induced expression of both <em>HO1</em> mRNA (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g003" rid-ob="ob-pone.0287788.g003" co-legend-rid="lgnd_pone.0287788.g003"><span>Fig 3C and 3D</span></a>) and protein (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g003" rid-ob="ob-pone.0287788.g003" co-legend-rid="lgnd_pone.0287788.g003"><span>Fig 3E</span></a>). Lansoprazole is suggested by these results to induce the expression of <em>HO1</em> mRNA and protein in an Nrf2-dependent manner. Furthermore, the effect of Nrf2 depletion on lansoprazole-mediated cytoprotection against cisplatin-induced cytotoxicity was assessed. RL34 cells were transfected with siNrf2 pools, followed by treatment with lansoprazole for 3 h. The cisplatin-induced cytotoxicity was then measured using an MTS assay. The cytotoxicity of cisplatin was increased in the Nrf2-knockdown cells to the same level as that observed in cells receiving a single administration of cisplatin (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g003" rid-ob="ob-pone.0287788.g003" co-legend-rid="lgnd_pone.0287788.g003"><span>Fig 3F</span></a>). The cytoprotective effect of lansoprazole is suggested to be dependent upon the Nrf2 pathway.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone.0287788.g003" co-legend-rid="lgnd_pone.0287788.g003"><a href="/pmc/articles/PMC10309994/figure/pone.0287788.g003/" target="figure" rid-figpopup="pone.0287788.g003" rid-ob="ob-pone.0287788.g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140276978816880"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10309994_pone.0287788.g003.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0287788.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10309994/bin/pone.0287788.g003.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140276978816880"><a target="object" rel="noopener" href="/pmc/articles/PMC10309994/figure/pone.0287788.g003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone.0287788.g003"><div><a class="figpopup" href="/pmc/articles/PMC10309994/figure/pone.0287788.g003/" target="figure" rid-figpopup="pone.0287788.g003" rid-ob="ob-pone.0287788.g003">Fig 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Nrf2 is essential for the cytoprotective activity of lansoprazole.</strong><p>A and B: Knockdown efficiency of siRNAs targeting Nrf2. RL34 cells were transfected with one of the two siRNAs targeting different sites in the rat <em>Nrf2</em> mRNA (5 nM) or with control siRNA (5 nM) for 24 h. <em>Nrf2</em> mRNA levels were measured using quantitative RT-PCR and were normalized to those of <em>&#x003b2;-actin</em> (A) or <em>GAPDH</em> (B). Results are expressed as a percentage of the mRNA levels of the samples treated with control siRNA. C and D: Effects of Nrf2 knockdown on the expression of the lansoprazole-induced gene <em>HO1</em> mRNA. Cells were transfected with 5 nM of control or pooled Nrf2 siRNA and, 24 h later, were treated with 100 &#x003bc;M of lansoprazole for 3 h. <em>HO1</em> mRNA levels were measured using quantitative RT-PCR; RNA levels were normalized to the <em>&#x003b2;-actin</em> (C) or <em>GAPDH</em> (D) mRNA level. Data represent the mean &#x000b1; SD of three independent experiments performed in triplicate. Statistical analysis was performed using Student&#x02019;s <em>t</em>-test. *: <em>p</em> &#x0003c; 0.05 <em>vs</em>. DMSO-treated control siRNA-transfected cells. E: Effects of Nrf2 knockdown on the expression of lansoprazole-induced Nrf2 and HO1 protein. Cells were transfected with 5 nM of control or pooled Nrf2 siRNA and then 24 h later were treated with 100 &#x003bc;M of lansoprazole for 3 h. Nrf2 and HO1 protein levels were measured using immunoblotting. &#x003b2;-actin served as a loading control. F: Effect of siRNA depletion of Nrf2 on the lansoprazole-mediated cytoprotection. siRNA-transfected cells were treated with 100 &#x003bc;M of lansoprazole for 3 h and then exposed to 20 &#x003bc;M of cisplatin for an additional 24 h. Cell viability was quantified using an MTS assay. Data are expressed as a percentage of viability when compared with DMSO-treated control siRNA-transfected cells. Data represent the mean &#x000b1; SD of three independent experiments performed in triplicate. Statistical analysis was performed by using ANOVA and Dunnett&#x02019;s test. *: <em>p</em> &#x0003c; 0.01 <em>vs</em>. cisplatin treatment group. Abbreviations: LPZ, lansoprazole; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt.</p></div></div></div></div><div id="sec019" class="sec"><h3 id="sec019title">Lansoprazole activates the p38 MAPK signaling but not ERK1/2 or JNK signaling</h3><p class="p p-first">The Nrf2 band was found to be upshifted in the nuclear fraction of the lansoprazole-treated cells (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g001" rid-ob="ob-pone.0287788.g001" co-legend-rid="lgnd_pone.0287788.g001"><span>Fig 1A</span></a>), indicating that Nrf2 translocated to the nucleus underwent posttranscriptional modifications. Phosphorylation is known to induce an upward shift of protein bands, so we examined the phosphorylation state of the Nrf2 in the nucleus. Nuclear fractions of the lansoprazole-treated cells were incubated in the presence or absence of &#x003bb;PPase, at 4&#x000b0;C or 30&#x000b0;C (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g004" rid-ob="ob-pone.0287788.g004" co-legend-rid="lgnd_pone.0287788.g004"><span>Fig 4A</span></a>). The nuclear Nrf2 incubated with phosphatase at 30&#x000b0;C exhibited a downshift on SDS-PAGE, whereas those incubated without the phosphatase (at 4&#x000b0;C and at 30&#x000b0;C) did not, indicating that Nrf2 is phosphorylated in the nucleus. The effect of lansoprazole on the phosphorylation of three major MAPKs (namely, p38 MAPK, ERK1/2, and JNK) were examined using RL34 cells (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g004" rid-ob="ob-pone.0287788.g004" co-legend-rid="lgnd_pone.0287788.g004"><span>Fig 4B</span></a>). The phosphorylation of p38 MAPK was enhanced in the lansoprazole-treated cells, whereas that of ERK1/2 and JNK had no apparent changes. Lansoprazole therefore specifically activates p38 MAPK, which subsequently plays an important role in the nuclear translocation of Nrf2 in RL34 cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone.0287788.g004" co-legend-rid="lgnd_pone.0287788.g004"><a href="/pmc/articles/PMC10309994/figure/pone.0287788.g004/" target="figure" rid-figpopup="pone.0287788.g004" rid-ob="ob-pone.0287788.g004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140276978806128"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10309994_pone.0287788.g004.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0287788.g004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10309994/bin/pone.0287788.g004.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140276978806128"><a target="object" rel="noopener" href="/pmc/articles/PMC10309994/figure/pone.0287788.g004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone.0287788.g004"><div><a class="figpopup" href="/pmc/articles/PMC10309994/figure/pone.0287788.g004/" target="figure" rid-figpopup="pone.0287788.g004" rid-ob="ob-pone.0287788.g004">Fig 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Lansoprazole activates p38 MAPK, but not ERK1/2 or JNK in RL34 cells.</strong><p>A: Detection of phosphorylated Nrf2 in the nucleus. RL34 cells were treated with lansoprazole for 3 h. Nuclear protein extracts from the cells were incubated with or without &#x003bb;PPase at 4&#x000b0;C or 30&#x000b0;C, for 30 min, and were analyzed using immunoblotting with an anti-Nrf2 antibody. B: Representative immunoblot for the phosphorylated and total p38 MAPK, ERK1/2, and JNK expression levels. RL34 cells were treated with 100 &#x003bc;M of lansoprazole for 3 h. Whole cell lysates from the cells were analyzed using immunoblotting with the indicated antibodies; &#x003b2;-actin served as a loading control (left). Densitometric quantification of representative immunoblots was performed using ImageJ. Values were normalized to &#x003b2;-actin protein levels. The ratio of the phosphorylated protein to total protein were also calculated (right). Data represent the mean &#x000b1; SD of three independent experiments performed in triplicate. Statistical analysis was performed using Student&#x02019;s <em>t</em>-test. *: <em>p</em> &#x0003c; 0.05 <em>vs</em>. DMSO-treated cells. Abbreviation: LPZ, lansoprazole.</p></div></div></div></div><div id="sec020" class="sec"><h3 id="sec020title">Activation of p38 MAPK is required for the lansoprazole-induced Nrf2/ARE pathway in RL34 cells</h3><p class="p p-first">A selective inhibitor of p38 MAPK (SB203580) was then used to investigate the role of p38 MAPK in the activation of the Nrf2/ARE pathway in RL34 cells [<a href="#pone.0287788.ref036" rid="pone.0287788.ref036" class=" bibr popnode">36</a>]. First, the effect of p38 MAPK on the Nrf2 upregulation by lansoprazole was examined. Immunoblotting analysis revealed that the lansoprazole-induced Nrf2 upregulation was completely inhibited by the addition of SB203580 (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g005" rid-ob="ob-pone.0287788.g005" co-legend-rid="lgnd_pone.0287788.g005"><span>Fig 5A</span></a>). Then inhibition of p38 MAPK by SB203580 completely canceled the lansoprazole-induced ARE-associated luciferase activity (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g005" rid-ob="ob-pone.0287788.g005" co-legend-rid="lgnd_pone.0287788.g005"><span>Fig 5B</span></a>) and the expression of HO1 (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g005" rid-ob="ob-pone.0287788.g005" co-legend-rid="lgnd_pone.0287788.g005"><span>Fig 5C and 5D</span></a>). Consistent with these data, immunofluorescence analysis revealed that the lansoprazole-induced nuclear translocation of Nrf2 was impaired by SB203580 (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g005" rid-ob="ob-pone.0287788.g005" co-legend-rid="lgnd_pone.0287788.g005"><span>Fig 5E</span></a>). SB203580 was suggested by these findings to have blocked the Nrf2/ARE pathway upstream of the nuclear translocation of Nrf2. p38 MAPK is therefore likely the key MAPK whose activation is required for the lansoprazole-induced HO1 expression in RL34 cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone.0287788.g005" co-legend-rid="lgnd_pone.0287788.g005"><a href="/pmc/articles/PMC10309994/figure/pone.0287788.g005/" target="figure" rid-figpopup="pone.0287788.g005" rid-ob="ob-pone.0287788.g005"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140276978791280"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10309994_pone.0287788.g005.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0287788.g005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10309994/bin/pone.0287788.g005.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140276978791280"><a target="object" rel="noopener" href="/pmc/articles/PMC10309994/figure/pone.0287788.g005/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone.0287788.g005"><div><a class="figpopup" href="/pmc/articles/PMC10309994/figure/pone.0287788.g005/" target="figure" rid-figpopup="pone.0287788.g005" rid-ob="ob-pone.0287788.g005">Fig 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Activation of p38 MAPK is required for the lansoprazole-induced ARE/Nrf2 pathway in RL34 cells.</strong><p>A: Effect of SB203580 on the induction of Nrf2 protein expression by lansoprazole. RL34 cells were treated with 10 &#x003bc;M of SB203580 (a specific p38 MAPK inhibitor) for 30 min, and then exposed to 100 &#x003bc;M of lansoprazole for an additional 3 h. Whole cell protein lysates were analyzed by immunoblotting with an anti-Nrf2 antibody; &#x003b2;-actin served as a loading control. B: Effect of SB203580 on the induction of the ARE-dependent reporter activity by lansoprazole. RL34 cells stably expressing the ARE-reporter gene were pretreated with 10 &#x003bc;M of SB203580 for 30 min, and then exposed to 100 &#x003bc;M of lansoprazole for an additional 3 h. Luciferase activity in the cell lysates was measured. C and D: Total RNA was isolated from the cells. Relative mRNA expression levels of <em>HO1</em> were measured by quantitative RT-PCR. RNA levels were normalized to <em>&#x003b2;-actin</em> (C) and <em>GAPDH</em> (D) mRNA level. Data represent the mean &#x000b1; SD of three independent experiments performed in triplicate. Student&#x02019;s <em>t</em>-test was employed for statistical analysis. *: <em>p</em> &#x0003c; 0.05 <em>vs</em>. untreated cells. E: Representative immunocytochemical images of the subcellular localization of Nrf2. RL34 cells were treated with 10 &#x003bc;M of SB203580 for 30 min and then exposed to 100 &#x003bc;M of lansoprazole for an additional 3 h. Cells were fixed in 4% PFA for 15 min, followed by a staining with anti-Nrf2 antibody and an Alexa Fluor 488-conjugated goat anti-rabbit IgG antibody; counterstaining of the nuclei was performed with Hoechst 33342. The scale bar represents 50 &#x003bc;m. Abbreviation: LPZ, lansoprazole.</p></div></div></div></div><div id="sec021" class="sec sec-last"><h3 id="sec021title">Activation of p38 MAPK is required for the cytoprotective activity of lansoprazole against cisplatin-induced toxicity</h3><p class="p p-first">We subsequently investigated whether the p38 MAPK pathway is involved in the cytoprotective activity of lansoprazole. RL34 cells were treated with lansoprazole for 3 h in the presence or absence of an SB203580 pretreatment and the MTS assay was used to determine the cell viability after exposure to cisplatin for 24 h. The inhibition of the p38 MAPK pathway by SB203580 completely restored the sensitivity to cisplatin in RL34 cells treated with lansoprazole (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g006" rid-ob="ob-pone.0287788.g006" co-legend-rid="lgnd_pone.0287788.g006"><span>Fig 6</span></a>). Cytoprotective activity of lansoprazole is therefore suggested to be through the p38 MAPK pathway.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone.0287788.g006" co-legend-rid="lgnd_pone.0287788.g006"><a href="/pmc/articles/PMC10309994/figure/pone.0287788.g006/" target="figure" rid-figpopup="pone.0287788.g006" rid-ob="ob-pone.0287788.g006"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140276978784128"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10309994_pone.0287788.g006.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0287788.g006.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10309994/bin/pone.0287788.g006.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140276978784128"><a target="object" rel="noopener" href="/pmc/articles/PMC10309994/figure/pone.0287788.g006/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone.0287788.g006"><div><a class="figpopup" href="/pmc/articles/PMC10309994/figure/pone.0287788.g006/" target="figure" rid-figpopup="pone.0287788.g006" rid-ob="ob-pone.0287788.g006">Fig 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Activation of p38 MAPK is required for the cytoprotective activity of lansoprazole against cisplatin-induced toxicity.</strong><p>Effect of SB203580 on the cytoprotective activity of lansoprazole. RL34 cells were treated with 100 &#x003bc;M of lansoprazole for 3 h in the presence or absence of 10 &#x003bc;M of an SB203580 (a specific p38 MAPK inhibitor) pretreatment for 30 min and were then exposed to 20 &#x003bc;M of cisplatin for an additional 24 h. Cell viability was quantified using an MTS assay. Data are expressed as a percentage of viability of nontreated cells. Data represent the mean &#x000b1; SD of three independent experiments performed in triplicate. Statistical analysis was performed using ANOVA followed by Tukey&#x02019;s test for multiple comparisons. *: <em>p</em> &#x0003c; 0.01. Abbreviations: LPZ, lansoprazole; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt.</p></div></div></div></div></div><div id="sec022" class="tsec sec"><h2 class="head no_bottom_margin" id="sec022title">Discussion</h2><p class="p p-first">The present study demonstrated that lansoprazole can activate the Nrf2/ARE-mediated antioxidant and phase 2 detoxifying gene expression, and can suppress cisplatin-induced cytotoxicity. These effects were completely canceled by knockdown of Nrf2 and inhibition of p38 MAPK, suggesting that the function of lansoprazole for inhibiting cisplatin-induced cell death is dependent on Nrf2 and p38 MAPK. In addition, the Nrf2 protein accumulated in the nucleus following lansoprazole treatment was phosphorylated, suggesting that this modification is involved in the anti-cell death function of lansoprazole. We previously reported that lansoprazole upregulates Nrf2 expression and attenuates the drug-induced oxidative liver injury in rats [<a href="#pone.0287788.ref032" rid="pone.0287788.ref032" class=" bibr popnode">32</a>, <a href="#pone.0287788.ref033" rid="pone.0287788.ref033" class=" bibr popnode">33</a>]. Lansoprazole has been reported to exhibit Nrf2-mediated antioxidant and anti-inflammatory effects in gastric mucosal cells [<a href="#pone.0287788.ref023" rid="pone.0287788.ref023" class=" bibr popnode">23</a>] and the small intestine [<a href="#pone.0287788.ref028" rid="pone.0287788.ref028" class=" bibr popnode">28</a>] and in the rat kidneys [<a href="#pone.0287788.ref037" rid="pone.0287788.ref037" class=" bibr popnode">37</a>]. Our data demonstrated that lansoprazole is a potent inducer of the Nrf2/ARE antioxidant pathway in hepatic cells, independently of its acid secretory-related actions (<a href="/pmc/articles/PMC10309994/figure/pone.0287788.g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0287788.g007" rid-ob="ob-pone.0287788.g007" co-legend-rid="lgnd_pone.0287788.g007"><span>Fig 7</span></a>). Lansoprazole is one of the most widely prescribed drugs worldwide, and is considered to have well-established safety and efficacy. Clinical application of lansoprazole is therefore expected to expand relatively quickly in the future as a treatment for liver diseases.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="pone.0287788.g007" co-legend-rid="lgnd_pone.0287788.g007"><a href="/pmc/articles/PMC10309994/figure/pone.0287788.g007/" target="figure" rid-figpopup="pone.0287788.g007" rid-ob="ob-pone.0287788.g007"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140276978772896"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10309994_pone.0287788.g007.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0287788.g007.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10309994/bin/pone.0287788.g007.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140276978772896"><a target="object" rel="noopener" href="/pmc/articles/PMC10309994/figure/pone.0287788.g007/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone.0287788.g007"><div><a class="figpopup" href="/pmc/articles/PMC10309994/figure/pone.0287788.g007/" target="figure" rid-figpopup="pone.0287788.g007" rid-ob="ob-pone.0287788.g007">Fig 7</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Lansoprazole activates the p38 MAPK/Nrf2/ARE pathway and suppresses cisplatin-induced cell death in RL34 cells.</strong><p>Schematic model of the Nrf2-dependent cytoprotective signaling pathway by lansoprazole in RL34 cells. Lansoprazole suppresses cisplatin-induced cytotoxicity through the activation of the Nrf2 pathway, accompanied by induction of antioxidant genes such as that encoding HO1. These effects are dependent on the p38 MAPK pathway.</p></div></div></div><p>Cisplatin is a commonly utilized chemotherapeutic agent, and confers toxicity to various tissues, including the liver. Growing evidence indicates that the production of ROS induced by cisplatin can trigger oxidative stress, and even cause cell death [<a href="#pone.0287788.ref016" rid="pone.0287788.ref016" class=" bibr popnode">16</a>&#x02013;<a href="#pone.0287788.ref018" rid="pone.0287788.ref018" class=" bibr popnode">18</a>, <a href="#pone.0287788.ref038" rid="pone.0287788.ref038" class=" bibr popnode">38</a>, <a href="#pone.0287788.ref039" rid="pone.0287788.ref039" class=" bibr popnode">39</a>]. Increased oxidative stress is one of the main mechanisms involved in cisplatin-induced hepatotoxicity, as indicated by both <em>in vitro</em> and <em>in vivo</em> studies [<a href="#pone.0287788.ref018" rid="pone.0287788.ref018" class=" bibr popnode">18</a>]. The activation of the Nrf2 signaling pathway has been associated with an increase in the expression of antioxidant enzymes and a decrease in ROS levels [<a href="#pone.0287788.ref040" rid="pone.0287788.ref040" class=" bibr popnode">40</a>&#x02013;<a href="#pone.0287788.ref042" rid="pone.0287788.ref042" class=" bibr popnode">42</a>]. An Nrf2 activator should therefore be expected to provide organ and cell protection against cisplatin-induced cytotoxicity. Consistent with previous reports, this study demonstrated that lansoprazole confers protective effects against cisplatin-induced cytotoxicity in RL34 cells. Marullo <em>et al</em>. showed that cisplatin induced direct damage to mitochondrial DNA, causing oxidative stress by increasing the intracellular ROS level [<a href="#pone.0287788.ref017" rid="pone.0287788.ref017" class=" bibr popnode">17</a>]. Mitochondria are the main source of ROS, so it can be inferred that lansoprazole can scavenge exogenous or endogenous ROS other than that induced by cisplatin. Lansoprazole could have wider clinical applications. The cisplatin-induced cytotoxicity model using RL34 cells employed in this study has been a useful model for the establishment of the cytoprotective mechanism of lansoprazole.</p><p>Nrf2 plays a crucial role in regulating cellular redox homeostasis, and protects cells from oxidative stress by inducing the transcriptional activation of antioxidant and phase II detoxifying enzymes through the ARE [<a href="#pone.0287788.ref043" rid="pone.0287788.ref043" class=" bibr popnode">43</a>&#x02013;<a href="#pone.0287788.ref045" rid="pone.0287788.ref045" class=" bibr popnode">45</a>]. Nrf2 protection of the liver from several hepatotoxicants has been shown in many studies, and this is known to be accompanied by induction of antioxidant genes encoding proteins, such as HO1 [<a href="#pone.0287788.ref003" rid="pone.0287788.ref003" class=" bibr popnode">3</a>]. Nrf2 activation was predicted to play a crucial role in the cytoprotective effect of lansoprazole. As expected, the siRNA-mediated knockdown of Nrf2 completely abolished the upregulation of HO1 as well as the cytoprotective effect of lansoprazole, whereas SnMP, an inhibitor of HO1, was able to partially block this effect. These results are inconsistent with those of previous studies [<a href="#pone.0287788.ref028" rid="pone.0287788.ref028" class=" bibr popnode">28</a>], and the induction of the HO1 expression did not fully account for the protective effect of lansoprazole. Lansoprazole has been observed to significantly increase the expression levels of <em>NQO1</em> and <em>GSTA2</em> mRNA. Furthermore, these Nrf2-regulated antioxidant genes may contribute to the cytoprotection of lansoprazole. One limitation of this study, based on previous reports [<a href="#pone.0287788.ref032" rid="pone.0287788.ref032" class=" bibr popnode">32</a>], is that sampling was conducted at 3 h after lansoprazole treatment, and stronger antioxidant activity could be observed if tested over a longer time course.</p><p>In this study, we attempted to elucidate the intracellular signal transduction mechanism of the hepatic protection by lansoprazole, and we subsequently used a rat hepatic RL34 cell culture model. Using <em>in vitro</em> phosphatase assay with RL34 cells, we showed that Nrf2 translocated to the nucleus (as a result of the lansoprazole treatment) is phosphorylated. Phosphorylation of Nrf2 is indicated to be involved in Nrf2 nuclear translocation and the activation of the ARE-associated gene transcription [<a href="#pone.0287788.ref046" rid="pone.0287788.ref046" class=" bibr popnode">46</a>, <a href="#pone.0287788.ref047" rid="pone.0287788.ref047" class=" bibr popnode">47</a>]. MAPK signaling (through p38 MAPK, ERK1/2, and JNK) may play an important role in the stress response, including the regulation of the Nrf2/ARE pathway [<a href="#pone.0287788.ref048" rid="pone.0287788.ref048" class=" bibr popnode">48</a>&#x02013;<a href="#pone.0287788.ref052" rid="pone.0287788.ref052" class=" bibr popnode">52</a>]. However, the involvement of MAPKs in the lansoprazole-induced pathway remains unclear. Takagi <em>et al</em>. reported the role of ERK in lansoprazole-induced expression of HO1 in rat gastric mucosal cell lines [<a href="#pone.0287788.ref023" rid="pone.0287788.ref023" class=" bibr popnode">23</a>], whereas Schulz-Geske <em>et al</em>. reported that lansoprazole-induced expression of HO1 without an activation of the MAPK pathways in NIH3T3 mouse embryonic fibroblasts [<a href="#pone.0287788.ref025" rid="pone.0287788.ref025" class=" bibr popnode">25</a>]. Remarkably, in RL34 cells, lansoprazole could induce the phosphorylation of p38 MAPK, but not that of ERK1/2 or JNK. Further experiments using SB203580, a specific inhibitor for p38 MAPK, confirmed the exclusive role of p38 MAPK in the lansoprazole-induced Nrf2/HO1 activation and cytoprotective effects. However, as a second limitation, our study could not demonstrate whether the p38 MAPK directly phosphorylates the Nrf2 in lansoprazole-treated cells. Further studies are required to define the direct association between p38 MAPK and Nrf2. As a crosstalk between different MAPK signaling pathways does not seem to occur, the RL34 cell line is a useful <em>in vitro</em> model for the study of the intracellular molecular mechanism of the lansoprazole-mediated Nrf2 pathway induction in hepatocytes. A third limitation is that the experiments were performed in only one cell line. Although lansoprazole caused exclusive p38 MAPK activation in RL34 cells, it is possible that other MAPK signaling pathways are activated in other cell types (e.g., human). Lansoprazole has in fact been reported to induce HO1 in gastric mucosal cell lines via the ERK pathway [<a href="#pone.0287788.ref023" rid="pone.0287788.ref023" class=" bibr popnode">23</a>] and in NIH3T3 mouse embryonic fibroblasts via the PI3K (the phosphatidylinositol 3-kinase) pathway, not the MAPK family [<a href="#pone.0287788.ref025" rid="pone.0287788.ref025" class=" bibr popnode">25</a>].</p><p>In basal conditions, Nrf2 activity is suppressed by the cytoplasmic repressor Keap1, which promotes its proteasome-dependent degradation. Most Nrf2 inducers are known to react with the cysteine residues of Keap1, causing a conformational change of the Keap1-Nrf2 complex [<a href="#pone.0287788.ref006" rid="pone.0287788.ref006" class=" bibr popnode">6</a>] and, thereby, obstructing the Nrf2 degradation. The newly generated Nrf2 accumulates and translocates into the nucleus. Takagi <em>et al</em>. showed that stimulation with lansoprazole can induce the oxidation of the Keap1 cysteine residues in gastric mucosal cells [<a href="#pone.0287788.ref023" rid="pone.0287788.ref023" class=" bibr popnode">23</a>]. In the current study, we found that treatment with lansoprazole can stabilize the Nrf2 protein. Lansoprazole was suggested to activate the Nrf2/ARE pathway by modifying the interaction between Keap1 and Nrf2, similarly to other Nrf2 inducers. However, as a fourth limitation, this study did not detect a direct modification of the Keap1 protein by lansoprazole. Further studies are required to demonstrate whether the hepatoprotective effect of lansoprazole results from a direct inactivation of Keap1 or from the regulation of the Keap1 inactivation by other upstream factors.</p><p>Lansoprazole is a prodrug that needs activation in an acidic environment such as the acidic secretory canaliculi for its anti-secretory effect [<a href="#pone.0287788.ref053" rid="pone.0287788.ref053" class=" bibr popnode">53</a>]. Our previous study showed that proton pump H+/K+-adenosine triphosphatase was not expressed in rat liver, and the cytoprotective effect of lansoprazole is therefore assumed to be mediated by an inactive form [<a href="#pone.0287788.ref032" rid="pone.0287788.ref032" class=" bibr popnode">32</a>]. Moreover, lansoprazole is metabolized mainly by CYP2C19 and CYP3A4 in the liver [<a href="#pone.0287788.ref054" rid="pone.0287788.ref054" class=" bibr popnode">54</a>], with the major metabolites being 5&#x02019;-hydroxy lansoprazole and the lansoprazole sulfone. As a fifth limitation, the present study could not determine whether the cytoprotective effect of lansoprazole was caused by acid-induced activation or metabolism by CYP enzymes, and this requires future investigation.</p><p>The concentration of 100 &#x003bc;M lansoprazole employed in this study is much higher than the maximum serum concentration in healthy adults given a single oral administration of 30 mg lansoprazole, which can be considered as a sixth limitation. However, the plasma concentration of lansoprazole does not correlate with tissue concentrations of lansoprazole. Lansoprazole accumulates in acidic tissue environments, where local concentrations have been proposed to reach millimolar levels [<a href="#pone.0287788.ref054" rid="pone.0287788.ref054" class=" bibr popnode">54</a>]. The regular clinical dosage of lansoprazole has been determined by the amount of acid suppression in the stomach. Data regarding optimal dosing is unavailable for <em>in vivo</em> studies of Nrf2-mediated hepatoprotective activity. Antioxidant effects on the liver in humans treated with lansoprazole have not been studied, and the optimal dosage requires investigation. As a seventh limitation, lansoprazole is reported to have anti-inflammatory effects [<a href="#pone.0287788.ref019" rid="pone.0287788.ref019" class=" bibr popnode">19</a>, <a href="#pone.0287788.ref020" rid="pone.0287788.ref020" class=" bibr popnode">20</a>], but the expression levels of inflammatory cytokines were not investigated in this study. Subsequent studies should therefore focus on inflammatory cytokines and investigate gene expression levels, focusing on those downstream of Nrf2. Furthermore, several reports have shown that lansoprazole can directly scavenge ROS as a substantial scavenger using chemical antioxidant assay [<a href="#pone.0287788.ref055" rid="pone.0287788.ref055" class=" bibr popnode">55</a>, <a href="#pone.0287788.ref056" rid="pone.0287788.ref056" class=" bibr popnode">56</a>]. Lansoprazole is suggested to have a direct antioxidant function in the liver, separate from its action via the p38 MAPK/Nrf2 signaling pathway.</p><p class="p p-last">In conclusion, our results demonstrate that lansoprazole confers cytoprotection against cisplatin-induced cell death through the activation of the Nrf2/ARE pathway and through the upregulation of antioxidant enzymes downstream of Nrf2 (that takes place <em>via</em> the p38 MAPK signaling pathway). Oxidative stress is the cause of most liver diseases, and it is a plausible therapeutic target to prevent liver damage [<a href="#pone.0287788.ref057" rid="pone.0287788.ref057" class=" bibr popnode">57</a>]. The induction of the antioxidant Nrf2 pathway may protect hepatic cells from oxidative stress and avoid the progression of disease. Various compounds have been postulated to increase Nrf2 activity, although an effective Nrf2 inducer is not currently available to counteract liver diseases. This study extended prior knowledge on the acid-independent effect of lansoprazole and provided novel insights into the mechanisms involved. Lansoprazole may therefore be a potential candidate for the treatment of liver diseases.</p></div><div id="sec023" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="sec023title">Supporting information</h2><!--/article/body/sec/--><div class="sec suppmat" id="pone.0287788.s001"><h4>S1 Raw images</h4><!--caption a9--><strong>Original uncropped images underlying all blots. </strong><p>This file contains all uncropped blot information. The asterisk indicates a nonspecific protein band.</p><p>(PDF)</p><div class="sup-box half_rhythm" id="media-a.s.e.b.c"><a href="/pmc/articles/PMC10309994/bin/pone.0287788.s001.pdf" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(3.5M, pdf)</sup></div></div><div class="sec suppmat" id="pone.0287788.s002"><h4>S1 Data</h4><p>(XLSX)</p><div class="sup-box half_rhythm" id="media-a.s.e.c.c"><a href="/pmc/articles/PMC10309994/bin/pone.0287788.s002.xlsx" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(34K, xlsx)</sup></div></div></div><div id="ack-a.t.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.t.atitle">Acknowledgments</h2><div class="sec"><p>We acknowledge proofreading and editing by Benjamin Phillis at the Clinical Study Support Center at Wakayama Medical University.</p></div></div><div id="funding-group-a.r.b.s" class="tsec sec"><h2 class="head no_bottom_margin" id="funding-group-a.r.b.stitle">Funding Statement</h2><p>This work was supported in part by a Japan Society for the Promotion of Science (JSPS) KAKENHI grant (grant no. 17K15963) to Naoko Yamagishi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></div><div id="notes-a.r.c" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.r.ctitle">Data Availability</h2><p>All relevant data are within the manuscript and its <a href="#sec023" rid="sec023" class=" sec">Supporting information</a> files.</p></div><div id="ref-list-a.t.b" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.t.btitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref001">1. <span class="mixed-citation">Al-Sawaf O, Clarner T, Fragoulis A, Kan YW, Pufe T, Streetz K, et al. <span class="ref-title">Nrf2 in health and disease: current and future clinical implications</span>. <span class="ref-journal">Clin Sci (Lond)</span>. 2015;<span class="ref-vol">129</span>(<span class="ref-iss">12</span>):989&#x02013;99. doi: 10.1042/CS20150436 . [<a href="https://pubmed.ncbi.nlm.nih.gov/26386022" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1042%2FCS20150436" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Sci+(Lond)&amp;title=Nrf2+in+health+and+disease:+current+and+future+clinical+implications&amp;author=O+Al-Sawaf&amp;author=T+Clarner&amp;author=A+Fragoulis&amp;author=YW+Kan&amp;author=T+Pufe&amp;volume=129&amp;issue=12&amp;publication_year=2015&amp;pages=989-99&amp;pmid=26386022&amp;doi=10.1042/CS20150436&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref002">2. <span class="mixed-citation">Zhang HQ, Davies KJA, Forman HJ. <span class="ref-title">Oxidative stress response and Nrf2 signaling in aging</span>. <span class="ref-journal">Free Radic Biol Med</span>. 2015;<span class="ref-vol">88</span>:314&#x02013;36. doi: 10.1016/j.freeradbiomed.2015.05.036 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4628850/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26066302" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.freeradbiomed.2015.05.036" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Free+Radic+Biol+Med&amp;title=Oxidative+stress+response+and+Nrf2+signaling+in+aging&amp;author=HQ+Zhang&amp;author=KJA+Davies&amp;author=HJ+Forman&amp;volume=88&amp;publication_year=2015&amp;pages=314-36&amp;pmid=26066302&amp;doi=10.1016/j.freeradbiomed.2015.05.036&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref003">3. <span class="mixed-citation">Liu J, Wu KC, Lu YF, Ekuase E, Klaassen CD. <span class="ref-title">NRF2 protection against liver injury produced by various hepatotoxicants</span>. <span class="ref-journal">Oxid Med Cell Longev</span>. 2013;<span class="ref-vol">2013</span>:305861. doi: 10.1155/2013/305861 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3676920/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23766851" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1155%2F2013%2F305861" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oxid+Med+Cell+Longev&amp;title=NRF2+protection+against+liver+injury+produced+by+various+hepatotoxicants&amp;author=J+Liu&amp;author=KC+Wu&amp;author=YF+Lu&amp;author=E+Ekuase&amp;author=CD+Klaassen&amp;volume=2013&amp;publication_year=2013&amp;pages=305861&amp;pmid=23766851&amp;doi=10.1155/2013/305861&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref004">4. <span class="mixed-citation">Bataille AM, Manautou JE. <span class="ref-title">Nrf2: a potential target for new therapeutics in liver disease</span>. <span class="ref-journal">Clin Pharmacol Ther</span>. 2012;<span class="ref-vol">92</span>(<span class="ref-iss">3</span>):340&#x02013;8. doi: 10.1038/clpt.2012.110 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3704160/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22871994" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fclpt.2012.110" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;title=Nrf2:+a+potential+target+for+new+therapeutics+in+liver+disease&amp;author=AM+Bataille&amp;author=JE+Manautou&amp;volume=92&amp;issue=3&amp;publication_year=2012&amp;pages=340-8&amp;pmid=22871994&amp;doi=10.1038/clpt.2012.110&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref005">5. <span class="mixed-citation">Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, et al. <span class="ref-title">Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</span>. <span class="ref-journal">Proc Natl Acad Sci U S A</span>. 2002;<span class="ref-vol">99</span>(<span class="ref-iss">18</span>):11908&#x02013;13. doi: 10.1073/pnas.172398899 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC129367/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12193649" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.172398899" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Direct+evidence+that+sulfhydryl+groups+of+Keap1+are+the+sensors+regulating+induction+of+phase+2+enzymes+that+protect+against+carcinogens+and+oxidants&amp;author=AT+Dinkova-Kostova&amp;author=WD+Holtzclaw&amp;author=RN+Cole&amp;author=K+Itoh&amp;author=N+Wakabayashi&amp;volume=99&amp;issue=18&amp;publication_year=2002&amp;pages=11908-13&amp;pmid=12193649&amp;doi=10.1073/pnas.172398899&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref006">6. <span class="mixed-citation">Suzuki T, Yamamoto M. <span class="ref-title">Molecular basis of the Keap1-Nrf2 system</span>. <span class="ref-journal">Free Radic Biol Med</span>. 2015;<span class="ref-vol">88</span>:93&#x02013;100. doi: 10.1016/j.freeradbiomed.2015.06.006 . [<a href="https://pubmed.ncbi.nlm.nih.gov/26117331" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.freeradbiomed.2015.06.006" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Free+Radic+Biol+Med&amp;title=Molecular+basis+of+the+Keap1-Nrf2+system&amp;author=T+Suzuki&amp;author=M+Yamamoto&amp;volume=88&amp;publication_year=2015&amp;pages=93-100&amp;pmid=26117331&amp;doi=10.1016/j.freeradbiomed.2015.06.006&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref007">7. <span class="mixed-citation">Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang M-I, Kobayashi A, Yamamoto M, et al. <span class="ref-title">Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers</span>. <span class="ref-journal">Proc Acad Sci U S A</span>. 2004;<span class="ref-vol">101</span>(<span class="ref-iss">7</span>):2040&#x02013;5. doi: 10.1073/pnas.0307301101 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC357048/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14764894" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.0307301101" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Acad+Sci+U+S+A&amp;title=Protection+against+electrophile+and+oxidant+stress+by+induction+of+the+phase+2+response:+fate+of+cysteines+of+the+Keap1+sensor+modified+by+inducers&amp;author=N+Wakabayashi&amp;author=AT+Dinkova-Kostova&amp;author=WD+Holtzclaw&amp;author=M-I+Kang&amp;author=A+Kobayashi&amp;volume=101&amp;issue=7&amp;publication_year=2004&amp;pages=2040-5&amp;pmid=14764894&amp;doi=10.1073/pnas.0307301101&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref008">8. <span class="mixed-citation">Furukawa M, Xiong Y. <span class="ref-title">BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase</span>. <span class="ref-journal">Mol Cell Biol</span>. 2005;<span class="ref-vol">25</span>(<span class="ref-iss">1</span>):162&#x02013;71. doi: 10.1128/MCB.25.1.162-171.2005 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC538799/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15601839" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1128%2FMCB.25.1.162-171.2005" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Biol&amp;title=BTB+protein+Keap1+targets+antioxidant+transcription+factor+Nrf2+for+ubiquitination+by+the+Cullin+3-Roc1+ligase&amp;author=M+Furukawa&amp;author=Y+Xiong&amp;volume=25&amp;issue=1&amp;publication_year=2005&amp;pages=162-71&amp;pmid=15601839&amp;doi=10.1128/MCB.25.1.162-171.2005&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref009">9. <span class="mixed-citation">Gong P, Stewart D, Hu B, Li N, Cook J, Nel A, et al. <span class="ref-title">Activation of the mouse heme oxygenase-1 gene by 15-deoxy-Delta(12,14)-prostaglandin J(2) is mediated by the stress response elements and transcription factor Nrf2</span>. <span class="ref-journal">Antioxid Redox Signal</span>. 2002;<span class="ref-vol">4</span>(<span class="ref-iss">2</span>):249&#x02013;57. doi: 10.1089/152308602753666307 . [<a href="https://pubmed.ncbi.nlm.nih.gov/12006176" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1089%2F152308602753666307" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antioxid+Redox+Signal&amp;title=Activation+of+the+mouse+heme+oxygenase-1+gene+by+15-deoxy-Delta(12,14)-prostaglandin+J(2)+is+mediated+by+the+stress+response+elements+and+transcription+factor+Nrf2&amp;author=P+Gong&amp;author=D+Stewart&amp;author=B+Hu&amp;author=N+Li&amp;author=J+Cook&amp;volume=4&amp;issue=2&amp;publication_year=2002&amp;pages=249-57&amp;pmid=12006176&amp;doi=10.1089/152308602753666307&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref010">10. <span class="mixed-citation">Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA. <span class="ref-title">Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis</span>. <span class="ref-journal">J Biol Chem</span>. 2003;<span class="ref-vol">278</span>(<span class="ref-iss">14</span>):12029&#x02013;38. doi: 10.1074/jbc.M211558200 . [<a href="https://pubmed.ncbi.nlm.nih.gov/12556532" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M211558200" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Identification+of+the+NF-E2-related+factor-2-dependent+genes+conferring+protection+against+oxidative+stress+in+primary+cortical+astrocytes+using+oligonucleotide+microarray+analysis&amp;author=JM+Lee&amp;author=MJ+Calkins&amp;author=K+Chan&amp;author=YW+Kan&amp;author=JA+Johnson&amp;volume=278&amp;issue=14&amp;publication_year=2003&amp;pages=12029-38&amp;pmid=12556532&amp;doi=10.1074/jbc.M211558200&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref011">11. <span class="mixed-citation">Satoh T, Okamoto SI, Cui J, Watanabe Y, Furuta K, Suzuki M, et al. <span class="ref-title">Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers</span>. <span class="ref-journal">Proc Natl Acad Sci U S A</span>. 2006;<span class="ref-vol">103</span>(<span class="ref-iss">3</span>):768&#x02013;73. doi: 10.1073/pnas.0505723102 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1334635/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16407140" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.0505723102" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Activation+of+the+Keap1/Nrf2+pathway+for+neuroprotection+by+electrophilic+[correction+of+electrophillic]+phase+II+inducers&amp;author=T+Satoh&amp;author=SI+Okamoto&amp;author=J+Cui&amp;author=Y+Watanabe&amp;author=K+Furuta&amp;volume=103&amp;issue=3&amp;publication_year=2006&amp;pages=768-73&amp;pmid=16407140&amp;doi=10.1073/pnas.0505723102&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref012">12. <span class="mixed-citation">Alam J, Wicks C, Stewart D, Gong P, Touchard C, Otterbein S, et al. <span class="ref-title">Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor</span>. <span class="ref-journal">J Biol Chem</span>. 2000;<span class="ref-vol">275</span>(<span class="ref-iss">36</span>):27694&#x02013;702. doi: 10.1074/jbc.M004729200 . [<a href="https://pubmed.ncbi.nlm.nih.gov/10874044" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M004729200" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Mechanism+of+heme+oxygenase-1+gene+activation+by+cadmium+in+MCF-7+mammary+epithelial+cells.+Role+of+p38+kinase+and+Nrf2+transcription+factor&amp;author=J+Alam&amp;author=C+Wicks&amp;author=D+Stewart&amp;author=P+Gong&amp;author=C+Touchard&amp;volume=275&amp;issue=36&amp;publication_year=2000&amp;pages=27694-702&amp;pmid=10874044&amp;doi=10.1074/jbc.M004729200&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref013">13. <span class="mixed-citation">Yu R, Chen C, Mo YY, Hebbar V, Owuor ED, Tan TH, et al. <span class="ref-title">Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism</span>. <span class="ref-journal">J Biol Chem</span>. 2000;<span class="ref-vol">275</span>(<span class="ref-iss">51</span>):39907&#x02013;13. doi: 10.1074/jbc.M004037200 . [<a href="https://pubmed.ncbi.nlm.nih.gov/10986282" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M004037200" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Activation+of+mitogen-activated+protein+kinase+pathways+induces+antioxidant+response+element-mediated+gene+expression+via+a+Nrf2-dependent+mechanism&amp;author=R+Yu&amp;author=C+Chen&amp;author=YY+Mo&amp;author=V+Hebbar&amp;author=ED+Owuor&amp;volume=275&amp;issue=51&amp;publication_year=2000&amp;pages=39907-13&amp;pmid=10986282&amp;doi=10.1074/jbc.M004037200&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref014">14. <span class="mixed-citation">Zipper LM, Mulcahy RT. <span class="ref-title">Inhibition of ERK and p38 MAP kinases inhibits binding of Nrf2 and induction of GCS genes</span>. <span class="ref-journal">Biochem Biophys Res Commun</span>. 2000;<span class="ref-vol">278</span>(<span class="ref-iss">2</span>):484&#x02013;92. doi: 10.1006/bbrc.2000.3830 . [<a href="https://pubmed.ncbi.nlm.nih.gov/11097862" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1006%2Fbbrc.2000.3830" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Inhibition+of+ERK+and+p38+MAP+kinases+inhibits+binding+of+Nrf2+and+induction+of+GCS+genes&amp;author=LM+Zipper&amp;author=RT+Mulcahy&amp;volume=278&amp;issue=2&amp;publication_year=2000&amp;pages=484-92&amp;pmid=11097862&amp;doi=10.1006/bbrc.2000.3830&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref015">15. <span class="mixed-citation">Iseri S, Ercan F, Gedik N, Yuksel M, Alican I. <span class="ref-title">Simvastatin attenuates cisplatin-induced kidney and liver damage in rats</span>. <span class="ref-journal">Toxicology</span>. 2007;<span class="ref-vol">230</span>(<span class="ref-iss">2&#x02013;3</span>):256&#x02013;64. doi: 10.1016/j.tox.2006.11.073 . [<a href="https://pubmed.ncbi.nlm.nih.gov/17196726" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.tox.2006.11.073" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Toxicology&amp;title=Simvastatin+attenuates+cisplatin-induced+kidney+and+liver+damage+in+rats&amp;author=S+Iseri&amp;author=F+Ercan&amp;author=N+Gedik&amp;author=M+Yuksel&amp;author=I+Alican&amp;volume=230&amp;issue=2&#x02013;3&amp;publication_year=2007&amp;pages=256-64&amp;pmid=17196726&amp;doi=10.1016/j.tox.2006.11.073&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref016">16. <span class="mixed-citation">Liao Y, Lu X, Lu C, Li G, Jin Y, Tang H. <span class="ref-title">Selection of agents for prevention of cisplatin-induced hepatotoxicity</span>. <span class="ref-journal">Pharmacol Res</span>. 2008;<span class="ref-vol">57</span>(<span class="ref-iss">2</span>):125&#x02013;31. doi: 10.1016/j.phrs.2008.01.001 . [<a href="https://pubmed.ncbi.nlm.nih.gov/18282716" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.phrs.2008.01.001" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Res&amp;title=Selection+of+agents+for+prevention+of+cisplatin-induced+hepatotoxicity&amp;author=Y+Liao&amp;author=X+Lu&amp;author=C+Lu&amp;author=G+Li&amp;author=Y+Jin&amp;volume=57&amp;issue=2&amp;publication_year=2008&amp;pages=125-31&amp;pmid=18282716&amp;doi=10.1016/j.phrs.2008.01.001&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref017">17. <span class="mixed-citation">Marullo R, Werner E, Degtyareva N, Moore B, Altavilla G, Ramalingam SS, et al. <span class="ref-title">Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions</span>. <span class="ref-journal">Plos One</span>. 2013;<span class="ref-vol">8</span>(<span class="ref-iss">11</span>). doi: 10.1371/journal.pone.0081162 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3834214/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24260552" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pone.0081162" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Plos+One&amp;title=Cisplatin+induces+a+mitochondrial-ROS+response+that+contributes+to+cytotoxicity+depending+on+mitochondrial+redox+status+and+bioenergetic+functions&amp;author=R+Marullo&amp;author=E+Werner&amp;author=N+Degtyareva&amp;author=B+Moore&amp;author=G+Altavilla&amp;volume=8&amp;issue=11&amp;publication_year=2013&amp;pmid=24260552&amp;doi=10.1371/journal.pone.0081162&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref018">18. <span class="mixed-citation">Yu W, Chen Y, Dubrulle J, Stossi F, Putluri V, Sreekumar A, et al. <span class="ref-title">Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism</span>. <span class="ref-journal">Sci Rep</span>. 2018;<span class="ref-vol">8</span>(<span class="ref-iss">1</span>):4306. doi: 10.1038/s41598-018-22640-y . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5844883/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29523854" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41598-018-22640-y" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Rep&amp;title=Cisplatin+generates+oxidative+stress+which+is+accompanied+by+rapid+shifts+in+central+carbon+metabolism&amp;author=W+Yu&amp;author=Y+Chen&amp;author=J+Dubrulle&amp;author=F+Stossi&amp;author=V+Putluri&amp;volume=8&amp;issue=1&amp;publication_year=2018&amp;pages=4306&amp;pmid=29523854&amp;doi=10.1038/s41598-018-22640-y&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref019">19. <span class="mixed-citation">Natale G, Lazzeri G, Lubrano V, Colucci R, Vassalle C, Fornai M, et al. <span class="ref-title">Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds</span>. <span class="ref-journal">Toxicol Appl Pharmacol</span>. 2004;<span class="ref-vol">195</span>(<span class="ref-iss">1</span>):62&#x02013;72. doi: 10.1016/j.taap.2003.10.006 . [<a href="https://pubmed.ncbi.nlm.nih.gov/14962506" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.taap.2003.10.006" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol+Appl+Pharmacol&amp;title=Mechanisms+of+gastroprotection+by+lansoprazole+pretreatment+against+experimentally+induced+injury+in+rats:+role+of+mucosal+oxidative+damage+and+sulfhydryl+compounds&amp;author=G+Natale&amp;author=G+Lazzeri&amp;author=V+Lubrano&amp;author=R+Colucci&amp;author=C+Vassalle&amp;volume=195&amp;issue=1&amp;publication_year=2004&amp;pages=62-72&amp;pmid=14962506&amp;doi=10.1016/j.taap.2003.10.006&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref020">20. <span class="mixed-citation">Blandizzi C, Fornai M, Colucci R, Natale G, Lubrano V, Vassalle C, et al. <span class="ref-title">Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage</span>. <span class="ref-journal">World J Gastroenterol</span>. 2005;<span class="ref-vol">11</span>(<span class="ref-iss">26</span>):4052&#x02013;60. doi: 10.3748/wjg.v11.i26.4052 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4502102/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15996031" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3748%2Fwjg.v11.i26.4052" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=World+J+Gastroenterol&amp;title=Lansoprazole+prevents+experimental+gastric+injury+induced+by+non-steroidal+anti-inflammatory+drugs+through+a+reduction+of+mucosal+oxidative+damage&amp;author=C+Blandizzi&amp;author=M+Fornai&amp;author=R+Colucci&amp;author=G+Natale&amp;author=V+Lubrano&amp;volume=11&amp;issue=26&amp;publication_year=2005&amp;pages=4052-60&amp;pmid=15996031&amp;doi=10.3748/wjg.v11.i26.4052&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref021">21. <span class="mixed-citation">Agnihotri N, Kaur H, Kaur N, Sarotra P. <span class="ref-title">Role of oxidative stress in lansoprazole-mediated gastric and hepatic protection in Wistar rats</span>. <span class="ref-journal">Indian J Gastroenterol</span>. 2007;<span class="ref-vol">26</span>(<span class="ref-iss">3</span>):118&#x02013;21. . [<a href="https://pubmed.ncbi.nlm.nih.gov/17704577" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Indian+J+Gastroenterol&amp;title=Role+of+oxidative+stress+in+lansoprazole-mediated+gastric+and+hepatic+protection+in+Wistar+rats&amp;author=N+Agnihotri&amp;author=H+Kaur&amp;author=N+Kaur&amp;author=P+Sarotra&amp;volume=26&amp;issue=3&amp;publication_year=2007&amp;pages=118-21&amp;pmid=17704577&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref022">22. <span class="mixed-citation">Tsuji S, Sun WH, Tsujii M, Kawai N, Kimura A, Kakiuchi Y, et al. <span class="ref-title">Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats</span>. <span class="ref-journal">J Pharmacol Exp Ther</span>. 2002;<span class="ref-vol">303</span>(<span class="ref-iss">3</span>):1301&#x02013;8. doi: 10.1124/jpet.102.035204 . [<a href="https://pubmed.ncbi.nlm.nih.gov/12438555" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1124%2Fjpet.102.035204" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=Lansoprazole+induces+mucosal+protection+through+gastrin+receptor-dependent+up-regulation+of+cyclooxygenase-2+in+rats&amp;author=S+Tsuji&amp;author=WH+Sun&amp;author=M+Tsujii&amp;author=N+Kawai&amp;author=A+Kimura&amp;volume=303&amp;issue=3&amp;publication_year=2002&amp;pages=1301-8&amp;pmid=12438555&amp;doi=10.1124/jpet.102.035204&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref023">23. <span class="mixed-citation">Takagi T, Naito Y, Okada H, Ishii T, Mizushima K, Akagiri S, et al. <span class="ref-title">Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of NF-E2-related factor 2 and oxidation of kelch-like ECH-associating protein 1</span>. <span class="ref-journal">J Pharmacol Exp Ther</span>. 2009;<span class="ref-vol">331</span>(<span class="ref-iss">1</span>):255&#x02013;64. doi: 10.1124/jpet.109.152702 . [<a href="https://pubmed.ncbi.nlm.nih.gov/19628634" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1124%2Fjpet.109.152702" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=Lansoprazole,+a+proton+pump+inhibitor,+mediates+anti-inflammatory+effect+in+gastric+mucosal+cells+through+the+induction+of+heme+oxygenase-1+via+activation+of+NF-E2-related+factor+2+and+oxidation+of+kelch-like+ECH-associating+protein+1&amp;author=T+Takagi&amp;author=Y+Naito&amp;author=H+Okada&amp;author=T+Ishii&amp;author=K+Mizushima&amp;volume=331&amp;issue=1&amp;publication_year=2009&amp;pages=255-64&amp;pmid=19628634&amp;doi=10.1124/jpet.109.152702&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref024">24. <span class="mixed-citation">Becker JC, Grosser N, Waltke C, Schulz S, Erdmann K, Domschke W, et al. <span class="ref-title">Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells</span>. <span class="ref-journal">BiBiochem Biophys</span>. 2006;<span class="ref-vol">345</span>(<span class="ref-iss">3</span>):1014&#x02013;21. doi: 10.1016/j.bbrc.2006.04.170 . [<a href="https://pubmed.ncbi.nlm.nih.gov/16712795" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.bbrc.2006.04.170" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BiBiochem+Biophys&amp;title=Beyond+gastric+acid+reduction:+proton+pump+inhibitors+induce+heme+oxygenase-1+in+gastric+and+endothelial+cells&amp;author=JC+Becker&amp;author=N+Grosser&amp;author=C+Waltke&amp;author=S+Schulz&amp;author=K+Erdmann&amp;volume=345&amp;issue=3&amp;publication_year=2006&amp;pages=1014-21&amp;pmid=16712795&amp;doi=10.1016/j.bbrc.2006.04.170&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref025">25. <span class="mixed-citation">Schulz-Geske S, Erdmann K, Wong RJ, Stevenson DK, Schroder H, Grosser N. <span class="ref-title">Molecular mechanism and functional consequences of lansoprazole-mediated heme oxygenase-1 induction</span>. <span class="ref-journal">World J Gastroentel</span>. 2009;<span class="ref-vol">15</span>(<span class="ref-iss">35</span>):4392&#x02013;401. doi: 10.3748/wjg.15.4392 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2747059/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19764090" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3748%2Fwjg.15.4392" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=World+J+Gastroentel&amp;title=Molecular+mechanism+and+functional+consequences+of+lansoprazole-mediated+heme+oxygenase-1+induction&amp;author=S+Schulz-Geske&amp;author=K+Erdmann&amp;author=RJ+Wong&amp;author=DK+Stevenson&amp;author=H+Schroder&amp;volume=15&amp;issue=35&amp;publication_year=2009&amp;pages=4392-401&amp;pmid=19764090&amp;doi=10.3748/wjg.15.4392&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref026">26. <span class="mixed-citation">Suzuki M, Nakamura M, Mori M, Miura S, Tsuchiya M, Ishii H. <span class="ref-title">Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori</span>. <span class="ref-journal">J Clin Gastroenterol</span>. 1995;<span class="ref-vol">20</span>
<span class="ref-iss">Suppl 2</span>:S93&#x02013;6. doi: 10.1097/00004836-199506002-00025 . [<a href="https://pubmed.ncbi.nlm.nih.gov/7594353" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1097%2F00004836-199506002-00025" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Gastroenterol&amp;title=Lansoprazole+inhibits+oxygen-derived+free+radical+production+from+neutrophils+activated+by+Helicobacter+pylori&amp;author=M+Suzuki&amp;author=M+Nakamura&amp;author=M+Mori&amp;author=S+Miura&amp;author=M+Tsuchiya&amp;volume=20&amp;issue=Suppl+2&amp;publication_year=1995&amp;pages=S93-6&amp;pmid=7594353&amp;doi=10.1097/00004836-199506002-00025&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref027">27. <span class="mixed-citation">Higuchi K, Yoda Y, Amagase K, Kato S, Tokioka S, Murano M, et al. <span class="ref-title">Prevention of NSAID-Induced Small Intestinal Mucosal Injury: Prophylactic Potential of Lansoprazole</span>. <span class="ref-journal">J Clin Biochem Nutr</span>. 2009;<span class="ref-vol">45</span>(<span class="ref-iss">2</span>):125&#x02013;30. doi: 10.3164/jcbn.SR09-58 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2735622/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19794918" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3164%2Fjcbn.SR09-58" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Biochem+Nutr&amp;title=Prevention+of+NSAID-Induced+Small+Intestinal+Mucosal+Injury:+Prophylactic+Potential+of+Lansoprazole&amp;author=K+Higuchi&amp;author=Y+Yoda&amp;author=K+Amagase&amp;author=S+Kato&amp;author=S+Tokioka&amp;volume=45&amp;issue=2&amp;publication_year=2009&amp;pages=125-30&amp;pmid=19794918&amp;doi=10.3164/jcbn.SR09-58&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref028">28. <span class="mixed-citation">Yoda Y, Amagase K, Kato S, Tokioka S, Murano M, Kakimoto K, et al. <span class="ref-title">Prevention by lansoprazole, a proton pump inhibitor, of indomethacin-induced small intestinal ulceration in rats through induction of heme oxygenase-1</span>. <span class="ref-journal">J Physiol Pharmacol: an official journal of the Polish Physiological Society</span>. 2010;<span class="ref-vol">61</span>(<span class="ref-iss">3</span>):287&#x02013;94. . [<a href="https://pubmed.ncbi.nlm.nih.gov/20610858" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Physiol+Pharmacol:+an+official+journal+of+the+Polish+Physiological+Society&amp;title=Prevention+by+lansoprazole,+a+proton+pump+inhibitor,+of+indomethacin-induced+small+intestinal+ulceration+in+rats+through+induction+of+heme+oxygenase-1&amp;author=Y+Yoda&amp;author=K+Amagase&amp;author=S+Kato&amp;author=S+Tokioka&amp;author=M+Murano&amp;volume=61&amp;issue=3&amp;publication_year=2010&amp;pages=287-94&amp;pmid=20610858&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref029">29. <span class="mixed-citation">Kuroda M, Yoshida N, Ichikawa H, Takagi T, Okuda T, Naito Y, et al. <span class="ref-title">Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis</span>. <span class="ref-journal">Int J Mol Med</span>. 2006;<span class="ref-vol">17</span>(<span class="ref-iss">1</span>):89&#x02013;93. . [<a href="https://pubmed.ncbi.nlm.nih.gov/16328016" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Mol+Med&amp;title=Lansoprazole,+a+proton+pump+inhibitor,+reduces+the+severity+of+indomethacin-induced+rat+enteritis&amp;author=M+Kuroda&amp;author=N+Yoshida&amp;author=H+Ichikawa&amp;author=T+Takagi&amp;author=T+Okuda&amp;volume=17&amp;issue=1&amp;publication_year=2006&amp;pages=89-93&amp;pmid=16328016&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref030">30. <span class="mixed-citation">Bauer M, Bauer I. <span class="ref-title">Heme oxygenase-1: redox regulation and role in the hepatic response to oxidative stress</span>. <span class="ref-journal">Antioxid Redox Signal</span>. 2002;<span class="ref-vol">4</span>(<span class="ref-iss">5</span>):749&#x02013;58. doi: 10.1089/152308602760598891 . [<a href="https://pubmed.ncbi.nlm.nih.gov/12470502" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1089%2F152308602760598891" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antioxid+Redox+Signal&amp;title=Heme+oxygenase-1:+redox+regulation+and+role+in+the+hepatic+response+to+oxidative+stress&amp;author=M+Bauer&amp;author=I+Bauer&amp;volume=4&amp;issue=5&amp;publication_year=2002&amp;pages=749-58&amp;pmid=12470502&amp;doi=10.1089/152308602760598891&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref031">31. <span class="mixed-citation">Zhu X, Fan WG, Li DP, Kung H, Lin MC. <span class="ref-title">Heme oxygenase-1 system and gastrointestinal inflammation: a short review</span>. <span class="ref-journal">World J Gastroenterol</span>. 2011;<span class="ref-vol">17</span>(<span class="ref-iss">38</span>):4283&#x02013;8. doi: 10.3748/wjg.v17.i38.4283 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3214703/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22090784" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3748%2Fwjg.v17.i38.4283" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=World+J+Gastroenterol&amp;title=Heme+oxygenase-1+system+and+gastrointestinal+inflammation:+a+short+review&amp;author=X+Zhu&amp;author=WG+Fan&amp;author=DP+Li&amp;author=H+Kung&amp;author=MC+Lin&amp;volume=17&amp;issue=38&amp;publication_year=2011&amp;pages=4283-8&amp;pmid=22090784&amp;doi=10.3748/wjg.v17.i38.4283&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref032">32. <span class="mixed-citation">Yamashita Y, Ueyama T, Nishi T, Yamamoto Y, Kawakoshi A, Sunami S, et al. <span class="ref-title">Nrf2-Inducing Anti-Oxidation Stress Response in the Rat Liver&#x02014;New Beneficial Effect of Lansoprazole</span>. <span class="ref-journal">Plos One</span>. 2014;<span class="ref-vol">9</span>(<span class="ref-iss">5</span>). doi: 10.1371/journal.pone.0097419 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4028208/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24846271" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pone.0097419" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Plos+One&amp;title=Nrf2-Inducing+Anti-Oxidation+Stress+Response+in+the+Rat+Liver&#x02014;New+Beneficial+Effect+of+Lansoprazole&amp;author=Y+Yamashita&amp;author=T+Ueyama&amp;author=T+Nishi&amp;author=Y+Yamamoto&amp;author=A+Kawakoshi&amp;volume=9&amp;issue=5&amp;publication_year=2014&amp;pmid=24846271&amp;doi=10.1371/journal.pone.0097419&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref033">33. <span class="mixed-citation">Nishi T, Yamamoto Y, Yamagishi N, Iguchi M, Tamai H, Ito T, et al. <span class="ref-title">Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model rats</span>. <span class="ref-journal">Journal of Pharmacy and Pharmacology</span>. 2018;<span class="ref-vol">70</span>(<span class="ref-iss">3</span>):383&#x02013;92. doi: 10.1111/jphp.12870 . [<a href="https://pubmed.ncbi.nlm.nih.gov/29355950" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fjphp.12870" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Pharmacy+and+Pharmacology&amp;title=Lansoprazole+prevents+the+progression+of+liver+fibrosis+in+non-alcoholic+steatohepatitis+model+rats&amp;author=T+Nishi&amp;author=Y+Yamamoto&amp;author=N+Yamagishi&amp;author=M+Iguchi&amp;author=H+Tamai&amp;volume=70&amp;issue=3&amp;publication_year=2018&amp;pages=383-92&amp;pmid=29355950&amp;doi=10.1111/jphp.12870&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref034">34. <span class="mixed-citation">Zhang DD, Hannink M. <span class="ref-title">Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress</span>. <span class="ref-journal">Mol Cell Biol</span>. 2003;<span class="ref-vol">23</span>(<span class="ref-iss">22</span>):8137&#x02013;51. doi: 10.1128/MCB.23.22.8137-8151.2003 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC262403/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14585973" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1128%2FMCB.23.22.8137-8151.2003" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Biol&amp;title=Distinct+cysteine+residues+in+Keap1+are+required+for+Keap1-dependent+ubiquitination+of+Nrf2+and+for+stabilization+of+Nrf2+by+chemopreventive+agents+and+oxidative+stress&amp;author=DD+Zhang&amp;author=M+Hannink&amp;volume=23&amp;issue=22&amp;publication_year=2003&amp;pages=8137-51&amp;pmid=14585973&amp;doi=10.1128/MCB.23.22.8137-8151.2003&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref035">35. <span class="mixed-citation">McMahon M, Itoh K, Yamamoto M, Hayes JD. <span class="ref-title">Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression</span>. <span class="ref-journal">J Biol Chem</span>. 2003;<span class="ref-vol">278</span>(<span class="ref-iss">24</span>):21592&#x02013;600. doi: 10.1074/jbc.M300931200 . [<a href="https://pubmed.ncbi.nlm.nih.gov/12682069" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M300931200" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Keap1-dependent+proteasomal+degradation+of+transcription+factor+Nrf2+contributes+to+the+negative+regulation+of+antioxidant+response+element-driven+gene+expression&amp;author=M+McMahon&amp;author=K+Itoh&amp;author=M+Yamamoto&amp;author=JD+Hayes&amp;volume=278&amp;issue=24&amp;publication_year=2003&amp;pages=21592-600&amp;pmid=12682069&amp;doi=10.1074/jbc.M300931200&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref036">36. <span class="mixed-citation">English JM, Cobb MH. <span class="ref-title">Pharmacological inhibitors of MAPK pathways</span>. <span class="ref-journal">Trends Pharmacol Sci</span>. 2002;<span class="ref-vol">23</span>(<span class="ref-iss">1</span>):40&#x02013;5. doi: 10.1016/s0165-6147(00)01865-4 . [<a href="https://pubmed.ncbi.nlm.nih.gov/11804650" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fs0165-6147(00)01865-4" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Pharmacol+Sci&amp;title=Pharmacological+inhibitors+of+MAPK+pathways&amp;author=JM+English&amp;author=MH+Cobb&amp;volume=23&amp;issue=1&amp;publication_year=2002&amp;pages=40-5&amp;pmid=11804650&amp;doi=10.1016/s0165-6147(00)01865-4&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref037">37. <span class="mixed-citation">Khaleel SA, Alzokaky AA, Raslan NA, Alwakeel AI, Abd El-Aziz HG, Abd-Allah AR. <span class="ref-title">Lansoprazole halts contrast induced nephropathy through activation of Nrf2 pathway in rats</span>. <span class="ref-journal">Chem Biol Interact</span>. 2017;<span class="ref-vol">270</span>:33&#x02013;40. doi: 10.1016/j.cbi.2017.04.010 . [<a href="https://pubmed.ncbi.nlm.nih.gov/28412091" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.cbi.2017.04.010" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chem+Biol+Interact&amp;title=Lansoprazole+halts+contrast+induced+nephropathy+through+activation+of+Nrf2+pathway+in+rats&amp;author=SA+Khaleel&amp;author=AA+Alzokaky&amp;author=NA+Raslan&amp;author=AI+Alwakeel&amp;author=HG+Abd+El-Aziz&amp;volume=270&amp;publication_year=2017&amp;pages=33-40&amp;pmid=28412091&amp;doi=10.1016/j.cbi.2017.04.010&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref038">38. <span class="mixed-citation">Koc A, Duru M, Ciralik H, Akcan R, Sogut S. <span class="ref-title">Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats</span>. <span class="ref-journal">Mol Cell Biochem</span>. 2005;<span class="ref-vol">278</span>(<span class="ref-iss">1&#x02013;2</span>):79&#x02013;84. doi: 10.1007/s11010-005-6630-z . [<a href="https://pubmed.ncbi.nlm.nih.gov/16180092" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs11010-005-6630-z" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Biochem&amp;title=Protective+agent,+erdosteine,+against+cisplatin-induced+hepatic+oxidant+injury+in+rats&amp;author=A+Koc&amp;author=M+Duru&amp;author=H+Ciralik&amp;author=R+Akcan&amp;author=S+Sogut&amp;volume=278&amp;issue=1&#x02013;2&amp;publication_year=2005&amp;pages=79-84&amp;pmid=16180092&amp;doi=10.1007/s11010-005-6630-z&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref039">39. <span class="mixed-citation">Naziroglu M, Karaoglu A, Aksoy AO. <span class="ref-title">Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats</span>. <span class="ref-journal">Toxicology</span>. 2004;<span class="ref-vol">195</span>(<span class="ref-iss">2&#x02013;3</span>):221&#x02013;30. doi: 10.1016/j.tox.2003.10.012 . [<a href="https://pubmed.ncbi.nlm.nih.gov/14751677" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.tox.2003.10.012" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Toxicology&amp;title=Selenium+and+high+dose+vitamin+E+administration+protects+cisplatin-induced+oxidative+damage+to+renal,+liver+and+lens+tissues+in+rats&amp;author=M+Naziroglu&amp;author=A+Karaoglu&amp;author=AO+Aksoy&amp;volume=195&amp;issue=2&#x02013;3&amp;publication_year=2004&amp;pages=221-30&amp;pmid=14751677&amp;doi=10.1016/j.tox.2003.10.012&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref040">40. <span class="mixed-citation">Taguchi K, Kensler TW. <span class="ref-title">Nrf2 in liver toxicology</span>. <span class="ref-journal">Arch Pharm Res</span>. 2020;<span class="ref-vol">43</span>(<span class="ref-iss">3</span>):337&#x02013;49. doi: 10.1007/s12272-019-01192-3 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7182086/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31782059" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs12272-019-01192-3" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Pharm+Res&amp;title=Nrf2+in+liver+toxicology&amp;author=K+Taguchi&amp;author=TW+Kensler&amp;volume=43&amp;issue=3&amp;publication_year=2020&amp;pages=337-49&amp;pmid=31782059&amp;doi=10.1007/s12272-019-01192-3&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref041">41. <span class="mixed-citation">Tian Y, Song W, Xu D, Chen X, Li X, Zhao Y. <span class="ref-title">Autophagy induced by ROS aggravates testis oxidative damage in diabetes via breaking the feedforward loop linking p62 and Nrf2</span>. <span class="ref-journal">Oxid Med Cell Longev</span>. 2020;<span class="ref-vol">2020</span>:7156579. doi: 10.1155/2020/7156579 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7254092/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32509151" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1155%2F2020%2F7156579" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oxid+Med+Cell+Longev&amp;title=Autophagy+induced+by+ROS+aggravates+testis+oxidative+damage+in+diabetes+via+breaking+the+feedforward+loop+linking+p62+and+Nrf2&amp;author=Y+Tian&amp;author=W+Song&amp;author=D+Xu&amp;author=X+Chen&amp;author=X+Li&amp;volume=2020&amp;publication_year=2020&amp;pages=7156579&amp;pmid=32509151&amp;doi=10.1155/2020/7156579&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref042">42. <span class="mixed-citation">Qu Z, Sun J, Zhang W, Yu J, Zhuang C. <span class="ref-title">Transcription factor NRF2 as a promising therapeutic target for Alzheimer&#x02019;s disease</span>. <span class="ref-journal">Free Radic Biol Med</span>. 2020;<span class="ref-vol">159</span>:87&#x02013;102. doi: 10.1016/j.freeradbiomed.2020.06.028 . [<a href="https://pubmed.ncbi.nlm.nih.gov/32730855" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.freeradbiomed.2020.06.028" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Free+Radic+Biol+Med&amp;title=Transcription+factor+NRF2+as+a+promising+therapeutic+target+for+Alzheimer&#x02019;s+disease&amp;author=Z+Qu&amp;author=J+Sun&amp;author=W+Zhang&amp;author=J+Yu&amp;author=C+Zhuang&amp;volume=159&amp;publication_year=2020&amp;pages=87-102&amp;pmid=32730855&amp;doi=10.1016/j.freeradbiomed.2020.06.028&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref043">43. <span class="mixed-citation">Hayes JD, McMahon M, Chowdhry S, Dinkova-Kostova AT. <span class="ref-title">Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway</span>. <span class="ref-journal">Antioxid Redox Signal</span>. 2010;<span class="ref-vol">13</span>(<span class="ref-iss">11</span>):1713&#x02013;48. doi: 10.1089/ars.2010.3221 . [<a href="https://pubmed.ncbi.nlm.nih.gov/20446772" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1089%2Fars.2010.3221" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antioxid+Redox+Signal&amp;title=Cancer+chemoprevention+mechanisms+mediated+through+the+Keap1-Nrf2+pathway&amp;author=JD+Hayes&amp;author=M+McMahon&amp;author=S+Chowdhry&amp;author=AT+Dinkova-Kostova&amp;volume=13&amp;issue=11&amp;publication_year=2010&amp;pages=1713-48&amp;pmid=20446772&amp;doi=10.1089/ars.2010.3221&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref044">44. <span class="mixed-citation">Jaiswal AK. <span class="ref-title">Nrf2 signaling in coordinated activation of antioxidant gene expression</span>. <span class="ref-journal">Free Radic Biol Med</span>. 2004;<span class="ref-vol">36</span>(<span class="ref-iss">10</span>):1199&#x02013;207. doi: 10.1016/j.freeradbiomed.2004.02.074 . [<a href="https://pubmed.ncbi.nlm.nih.gov/15110384" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.freeradbiomed.2004.02.074" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Free+Radic+Biol+Med&amp;title=Nrf2+signaling+in+coordinated+activation+of+antioxidant+gene+expression&amp;author=AK+Jaiswal&amp;volume=36&amp;issue=10&amp;publication_year=2004&amp;pages=1199-207&amp;pmid=15110384&amp;doi=10.1016/j.freeradbiomed.2004.02.074&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref045">45. <span class="mixed-citation">Kaspar JW, Niture SK, Jaiswal AK. <span class="ref-title">Nrf2:INrf2 (Keap1) signaling in oxidative stress</span>. <span class="ref-journal">Free Radic Biol Med</span>. 2009;<span class="ref-vol">47</span>(<span class="ref-iss">9</span>):1304&#x02013;9. doi: 10.1016/j.freeradbiomed.2009.07.035 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2763938/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19666107" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.freeradbiomed.2009.07.035" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Free+Radic+Biol+Med&amp;title=Nrf2:INrf2+(Keap1)+signaling+in+oxidative+stress&amp;author=JW+Kaspar&amp;author=SK+Niture&amp;author=AK+Jaiswal&amp;volume=47&amp;issue=9&amp;publication_year=2009&amp;pages=1304-9&amp;pmid=19666107&amp;doi=10.1016/j.freeradbiomed.2009.07.035&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref046">46. <span class="mixed-citation">Zipper LM, Mulcahy RT. <span class="ref-title">Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells</span>. <span class="ref-journal">Toxicol Sci</span>. 2003;<span class="ref-vol">73</span>(<span class="ref-iss">1</span>):124&#x02013;34. doi: 10.1093/toxsci/kfg083 . [<a href="https://pubmed.ncbi.nlm.nih.gov/12657749" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1093%2Ftoxsci%2Fkfg083" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol+Sci&amp;title=Erk+activation+is+required+for+Nrf2+nuclear+localization+during+pyrrolidine+dithiocarbamate+induction+of+glutamate+cysteine+ligase+modulatory+gene+expression+in+HepG2+cells&amp;author=LM+Zipper&amp;author=RT+Mulcahy&amp;volume=73&amp;issue=1&amp;publication_year=2003&amp;pages=124-34&amp;pmid=12657749&amp;doi=10.1093/toxsci/kfg083&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref047">47. <span class="mixed-citation">Chen HH, Wang TC, Lee YC, Shen PT, Chang JY, Yeh TK, et al. <span class="ref-title">Novel Nrf2/ARE activator, trans-Coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38&#x003b1;/MAPKAPK-2 and PK-N3 signaling pathway</span>. <span class="ref-journal">Chem Res Toxicol</span>. 2015;<span class="ref-vol">28</span>(<span class="ref-iss">9</span>):1681&#x02013;92. doi: 10.1021/acs.chemrestox.5b00085 . [<a href="https://pubmed.ncbi.nlm.nih.gov/26275128" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1021%2Facs.chemrestox.5b00085" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chem+Res+Toxicol&amp;title=Novel+Nrf2/ARE+activator,+trans-Coniferylaldehyde,+induces+a+HO-1-mediated+defense+mechanism+through+a+dual+p38&#x003b1;/MAPKAPK-2+and+PK-N3+signaling+pathway&amp;author=HH+Chen&amp;author=TC+Wang&amp;author=YC+Lee&amp;author=PT+Shen&amp;author=JY+Chang&amp;volume=28&amp;issue=9&amp;publication_year=2015&amp;pages=1681-92&amp;pmid=26275128&amp;doi=10.1021/acs.chemrestox.5b00085&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref048">48. <span class="mixed-citation">Bryan HK, Olayanju A, Goldring CE, Park BK. <span class="ref-title">The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation</span>. <span class="ref-journal">Biochem Pharmacol</span>. 2013;<span class="ref-vol">85</span>(<span class="ref-iss">6</span>):705&#x02013;17. doi: 10.1016/j.bcp.2012.11.016 . [<a href="https://pubmed.ncbi.nlm.nih.gov/23219527" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.bcp.2012.11.016" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;title=The+Nrf2+cell+defence+pathway:+Keap1-dependent+and+-independent+mechanisms+of+regulation&amp;author=HK+Bryan&amp;author=A+Olayanju&amp;author=CE+Goldring&amp;author=BK+Park&amp;volume=85&amp;issue=6&amp;publication_year=2013&amp;pages=705-17&amp;pmid=23219527&amp;doi=10.1016/j.bcp.2012.11.016&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref049">49. <span class="mixed-citation">Keum YS, Yu S, Chang PP, Yuan X, Kim JH, Xu C, et al. <span class="ref-title">Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells</span>. <span class="ref-journal">Cancer Res</span>. 2006;<span class="ref-vol">66</span>(<span class="ref-iss">17</span>):8804&#x02013;13. doi: 10.1158/0008-5472.CAN-05-3513 . [<a href="https://pubmed.ncbi.nlm.nih.gov/16951197" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F0008-5472.CAN-05-3513" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Mechanism+of+action+of+sulforaphane:+inhibition+of+p38+mitogen-activated+protein+kinase+isoforms+contributing+to+the+induction+of+antioxidant+response+element-mediated+heme+oxygenase-1+in+human+hepatoma+HepG2+cells&amp;author=YS+Keum&amp;author=S+Yu&amp;author=PP+Chang&amp;author=X+Yuan&amp;author=JH+Kim&amp;volume=66&amp;issue=17&amp;publication_year=2006&amp;pages=8804-13&amp;pmid=16951197&amp;doi=10.1158/0008-5472.CAN-05-3513&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref050">50. <span class="mixed-citation">Yuan X, Xu C, Pan Z, Keum YS, Kim JH, Shen G, et al. <span class="ref-title">Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells</span>. <span class="ref-journal">Mol Carcinog</span>. 2006;<span class="ref-vol">45</span>(<span class="ref-iss">11</span>):841&#x02013;50. doi: 10.1002/mc.20234 . [<a href="https://pubmed.ncbi.nlm.nih.gov/16739127" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fmc.20234" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Carcinog&amp;title=Butylated+hydroxyanisole+regulates+ARE-mediated+gene+expression+via+Nrf2+coupled+with+ERK+and+JNK+signaling+pathway+in+HepG2+cells&amp;author=X+Yuan&amp;author=C+Xu&amp;author=Z+Pan&amp;author=YS+Keum&amp;author=JH+Kim&amp;volume=45&amp;issue=11&amp;publication_year=2006&amp;pages=841-50&amp;pmid=16739127&amp;doi=10.1002/mc.20234&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref051">51. <span class="mixed-citation">Nguyen T, Sherratt PJ, Huang HC, Yang CS, Pickett CB. <span class="ref-title">Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome</span>. <span class="ref-journal">J Biol Chem</span>. 2003;<span class="ref-vol">278</span>(<span class="ref-iss">7</span>):4536&#x02013;41. doi: 10.1074/jbc.M207293200 . [<a href="https://pubmed.ncbi.nlm.nih.gov/12446695" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M207293200" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Increased+protein+stability+as+a+mechanism+that+enhances+Nrf2-mediated+transcriptional+activation+of+the+antioxidant+response+element.+Degradation+of+Nrf2+by+the+26+S+proteasome&amp;author=T+Nguyen&amp;author=PJ+Sherratt&amp;author=HC+Huang&amp;author=CS+Yang&amp;author=CB+Pickett&amp;volume=278&amp;issue=7&amp;publication_year=2003&amp;pages=4536-41&amp;pmid=12446695&amp;doi=10.1074/jbc.M207293200&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref052">52. <span class="mixed-citation">Yu R, Lei W, Mandlekar S, Weber MJ, Der CJ, Wu J, et al. <span class="ref-title">Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals</span>. <span class="ref-journal">J Biol Chem</span>. 1999;<span class="ref-vol">274</span>(<span class="ref-iss">39</span>):27545&#x02013;52. doi: 10.1074/jbc.274.39.27545 . [<a href="https://pubmed.ncbi.nlm.nih.gov/10488090" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.274.39.27545" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Role+of+a+mitogen-activated+protein+kinase+pathway+in+the+induction+of+phase+II+detoxifying+enzymes+by+chemicals&amp;author=R+Yu&amp;author=W+Lei&amp;author=S+Mandlekar&amp;author=MJ+Weber&amp;author=CJ+Der&amp;volume=274&amp;issue=39&amp;publication_year=1999&amp;pages=27545-52&amp;pmid=10488090&amp;doi=10.1074/jbc.274.39.27545&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref053">53. <span class="mixed-citation">Landes BD, Petite JP, Flouvat B. <span class="ref-title">Clinical pharmacokinetics of lansoprazole</span>. <span class="ref-journal">Clin Pharmacokinet</span>. 1995;<span class="ref-vol">28</span>(<span class="ref-iss">6</span>):458&#x02013;70. doi: 10.2165/00003088-199528060-00004 . [<a href="https://pubmed.ncbi.nlm.nih.gov/7656504" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2165%2F00003088-199528060-00004" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacokinet&amp;title=Clinical+pharmacokinetics+of+lansoprazole&amp;author=BD+Landes&amp;author=JP+Petite&amp;author=B+Flouvat&amp;volume=28&amp;issue=6&amp;publication_year=1995&amp;pages=458-70&amp;pmid=7656504&amp;doi=10.2165/00003088-199528060-00004&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref054">54. <span class="mixed-citation">Shin JM, Kim N. <span class="ref-title">Pharmacokinetics and pharmacodynamics of the proton pump inhibitors</span>. <span class="ref-journal">J Neurogastroenterol Motil</span>. 2013;<span class="ref-vol">19</span>(<span class="ref-iss">1</span>):25&#x02013;35. doi: 10.5056/jnm.2013.19.1.25 . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3548122/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23350044" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.5056%2Fjnm.2013.19.1.25" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurogastroenterol+Motil&amp;title=Pharmacokinetics+and+pharmacodynamics+of+the+proton+pump+inhibitors&amp;author=JM+Shin&amp;author=N+Kim&amp;volume=19&amp;issue=1&amp;publication_year=2013&amp;pages=25-35&amp;pmid=23350044&amp;doi=10.5056/jnm.2013.19.1.25&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref055">55. <span class="mixed-citation">Simon WA, Sturm E, Hartmann HJ, Weser U. <span class="ref-title">Hydroxyl radical scavenging reactivity of proton pump inhibitors</span>. <span class="ref-journal">Biochem Pharmacol</span>. 2006;<span class="ref-vol">71</span>(<span class="ref-iss">9</span>):1337&#x02013;41. doi: 10.1016/j.bcp.2006.01.009 . [<a href="https://pubmed.ncbi.nlm.nih.gov/16494850" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.bcp.2006.01.009" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;title=Hydroxyl+radical+scavenging+reactivity+of+proton+pump+inhibitors&amp;author=WA+Simon&amp;author=E+Sturm&amp;author=HJ+Hartmann&amp;author=U+Weser&amp;volume=71&amp;issue=9&amp;publication_year=2006&amp;pages=1337-41&amp;pmid=16494850&amp;doi=10.1016/j.bcp.2006.01.009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref056">56. <span class="mixed-citation">Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E, Banerjee RK. <span class="ref-title">A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical</span>. <span class="ref-journal">J Biol Chem</span>. 2003;<span class="ref-vol">278</span>(<span class="ref-iss">13</span>):10993&#x02013;1001. doi: 10.1074/jbc.M210328200 . [<a href="https://pubmed.ncbi.nlm.nih.gov/12529378" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1074%2Fjbc.M210328200" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=A+novel+antioxidant+and+antiapoptotic+role+of+omeprazole+to+block+gastric+ulcer+through+scavenging+of+hydroxyl+radical&amp;author=K+Biswas&amp;author=U+Bandyopadhyay&amp;author=I+Chattopadhyay&amp;author=A+Varadaraj&amp;author=E+Ali&amp;volume=278&amp;issue=13&amp;publication_year=2003&amp;pages=10993-1001&amp;pmid=12529378&amp;doi=10.1074/jbc.M210328200&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0287788.ref057">57. <span class="mixed-citation">Ramos-Tovar E, Muriel P. <span class="ref-title">Free radicals, antioxidants, nuclear factor-E2-related factor-2 and liver damage</span>. <span class="ref-journal">J Appl Toxicol</span>. 2020;<span class="ref-vol">40</span>(<span class="ref-iss">1</span>):151&#x02013;68. doi: 10.1002/jat.3880 . [<a href="https://pubmed.ncbi.nlm.nih.gov/31389060" ref="reftype=pubmed&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fjat.3880" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Appl+Toxicol&amp;title=Free+radicals,+antioxidants,+nuclear+factor-E2-related+factor-2+and+liver+damage&amp;author=E+Ramos-Tovar&amp;author=P+Muriel&amp;volume=40&amp;issue=1&amp;publication_year=2020&amp;pages=151-68&amp;pmid=31389060&amp;doi=10.1002/jat.3880&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><div class="sub-navigation nav-top space small"><ul class="page-breadcrumbs inline_list small"><li><a href="#top" class="navlink">PLoS One. 2023; 18(6): e0287788. </a></li><span> » </span><li>Decision Letter 0</li></ul></div><div class="sub-content half_rhythm" id="pone.0287788.r001"><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="part1"><span class="cit-abbr"> </span><span class="cit-pub-date">2023; </span><span class="cit-vol">18</span><span class="cit-iss">(6)</span><span class="cit-flpgs">: e0287788. </span></div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 Jun 29. </span><span class="doi"><span>doi: </span><a href="//doi.org/10.1371%2Fjournal.pone.0287788.r001" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0287788.r001</a></span></div></div></div><h1 class="sub-content-title">Decision Letter 0</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yap%20WH%5BAuthor%5D">Wei Hsum Yap</a>, <span class="fm-role">Academic Editor</span></div><div style="display:none" class="contrib-group aff-tip"></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"> <a href="#" class="pmctoggle" rid="idm140276940120544_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info half_rhythm"><div></div></div><div class="fm-article-notes half_rhythm"></div><div class="permissions half_rhythm hide" id="idm140276940120544_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2023 Wei Hsum Yap</div><div class="fm-copyright half_rhythm">This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</div></div></div></div><div id="body-a.u.b" class="tsec sec"><h2 class="headless nomenu"></h2><p class="p p-first">
<em class="letter-date">6 Mar 2023</em>
</p><p>PONE-D-22-35612Activation of p38 MAPK signaling is required for lansoprazole-mediated Nrf2 activation&#x000a0;and cytoprotective effects against cisplatin toxicity in rat hepatic RL34 cells.PLOS ONE</p><p>Dear Dr. Yamagishi,</p><p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE&#x02019;s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p><p>Please submit your revised manuscript by Apr 20 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at&#x000a0;<a href="mailto:dev@null" data-email="gro.solp@enosolp" class="oemail">gro.solp@enosolp</a>. When you're ready to submit your revision, log on to <a href="https://www.editorialmanager.com/pone/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://www.editorialmanager.com/pone/</a> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p><p>Please include the following items when submitting your revised manuscript:</p><ul class="unordered" style="list-style-type:disc"><li><div>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</div></li><li><div>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</div></li><li><div>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</div></li></ul><p></p><p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p><p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <a href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</a>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <a href="https://plos.org/protocols?utm_medium=editorial-email&#x00026;utm_source=authorletters&#x00026;utm_campaign=protocols" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://plos.org/protocols?utm_medium=editorial-email&#x00026;utm_source=authorletters&#x00026;utm_campaign=protocols</a>.</p><p>We look forward to receiving your revised manuscript.</p><p>Kind regards,</p><p>Wei Hsum Yap</p><p>Academic Editor</p><p>PLOS ONE</p><p>Journal Requirements:</p><p>When submitting your revision, we need you to address these additional requirements.</p><p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p><p><a href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</a> and</p><p>
<a href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</a>
</p><p>2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at <a href="https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code</a> and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.</p><p>3. Thank you for stating the following in the Acknowledgments Section of your manuscript:</p><p>&#x0201c;This work was supported in part by a Japan Society for the Promotion of Science 478 (JSPS) KAKENHI grant (grant no. 17K15963) to N. Yamagishi.&#x0201d;</p><p>We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.</p><p>Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:</p><p>&#x0201c;This work was supported in part by a Japan Society for the Promotion of Science (JSPS) KAKENHI grant (grant no. 17K15963) to Naoko Yamagishi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.&#x0201d;</p><p>Please include your amended statements within your cover letter; we will change the online submission form on your behalf.</p><p>4. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission&#x02019;s figures or Supporting Information files. This policy and the journal&#x02019;s other requirements for blot/gel reporting and figure preparation are described in detail at <a href="https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements</a> and <a href="https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files</a>. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: <a href="https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels</a>.</p><p>In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at <a href="mailto:dev@null" data-email="gro.solp@enosolp" class="oemail">gro.solp@enosolp</a> if you have any questions.</p><p>5. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see <a href="http://journals.plos.org/plosone/s/data-availability" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://journals.plos.org/plosone/s/data-availability</a>.</p><p>Upon re-submitting your revised manuscript, please upload your study&#x02019;s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see <a href="http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories</a>. Any potentially identifying patient information must be fully anonymized.</p><p>Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: <a href="http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions</a>. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.</p><p>We will update your Data Availability statement to reflect the information you provide in your cover letter.</p><p>6. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.</p><p>Additional Editor Comments:</p><p>Please revise the manuscript to enhance clarity of the submission.</p><p>[Note: HTML markup is below. Please do not edit.]</p><p>Reviewers' comments:</p><p>Reviewer's Responses to Questions</p><p>

<strong>Comments to the Author</strong>
</p><p>1. Is the manuscript technically sound, and do the data support the conclusions?</p><p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p><p>Reviewer #1:&#x000a0;Yes</p><p>Reviewer #2:&#x000a0;Partly</p><p>**********</p><p>2. Has the statistical analysis been performed appropriately and rigorously? </p><p>Reviewer #1:&#x000a0;I Don't Know</p><p>Reviewer #2:&#x000a0;Yes</p><p>**********</p><p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p><p>The <a href="http://www.plosone.org/static/policies.action#sharing" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">PLOS Data policy</a> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data&#x02014;e.g. participant privacy or use of data from a third party&#x02014;those must be specified.</p><p>Reviewer #1:&#x000a0;No</p><p>Reviewer #2:&#x000a0;Yes</p><p>**********</p><p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p><p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p><p>Reviewer #1:&#x000a0;Yes</p><p>Reviewer #2:&#x000a0;Yes</p><p>**********</p><p>5. Review Comments to the Author</p><p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p><p>Reviewer #1:&#x000a0;This manuscript is very interesting and poses lansoprazole as a potential therapeutic target for oxidative stress to the liver. However, the data could be presented in a more clear fashion, and the wording in some areas could be improved.</p><p>Reviewer #2:&#x000a0;Overview:</p><p>Generally, the manuscript presented the novelty of the study in elucidating the potential molecular mechanisms of lansoprazole in cisplatin-induced hepatoxicity in rat hepatic RL34 cells. This manuscript provides an insightful scientific impact on the molecular mechanisms of lansoprazole. The study design and method used were reliable, yet the reporting in methods and results require improvements.</p><p>Some recommendations have been suggested as below for revision.</p><p>Strengths:</p><p>1. This paper presented novel insights on the mechanisms of lansoprazole.</p><p>2. The method used was robust and reliable.</p><p>Limitations:</p><p>1. Poor reporting in methodology and result.</p><p>2. Gene expression study with 1 housekeeping gene is less convincing.</p><p>Title: Title is too length with too many unnecessary words. Suggest to revise.</p><p>Abstract:</p><p>1. Line 14; 28: Kindly avoid the use of first- and second-person pronouns (i.e. we) in the abstract. Please use active voice and third-person narrative throughout the manuscript.</p><p>2. Line 20: Typo for &#x02018;NAD(P)H:1quinone oxidoreductase-1&#x02019;? It should be written as &#x02018;NAD(P)H quinone oxidoreductase-1&#x02019;.</p><p>3. Method was not mentioned in the abstract.</p><p>Introduction</p><p>1. Line 48: &#x02018;The nuclear Nrf2&#x02026;&#x02019;</p><p>2. Line 72 - 79: Kindly avoid the use of first- and second-person pronouns (i.e. we) in the abstract. Please use active voice and third-person narrative.</p><p>3. Suggest to include the relationship of nrf-2 with p38 and Erk1 in introduction to provide an better overview on the signaling pathway involved and further justified on the choice of antibodies used in Western blotting.</p><p>Methods</p><p>1. Some chemicals or materials only provided with brand name without the city and country of manufacturing, including FBS, DMSO, DMEM, MTS reagent, lansoprazole, RIPA buffer, hygromycin, luciferase assay, anti-rabbit IgG antibody.</p><p>2. How many replicates run in cell viability assay (MTS)? How many sets of experiment samples per replicate? Please mention in the method.</p><p>3. Line 106: What 96-well plate reader was used? Please specify the brand of equipment along with the city and country.</p><p>4. Line 134: CHX abbreviation was used without providing the full term when it was first introduced in the text.</p><p>5. Line 140: Version, city and country of ImageJ?</p><p>6. Line 151: The amount of total RNA used to reverse-transcribed into cDNA was not mentioned.</p><p>7. The experiment setting for gene expression in PCR assay was unclear: volume of reaction mix of PCR, thermal cycling condition, number of replicates, negative control, the validation or optimization of primers, etc.</p><p>8. Line 157: Only one housekeeping gene was used (beta actin), which is insufficient and at least two housekeeping genes are require for in vitro experiments. Based on MIQE guideline for qPCR, normalization of samples obtained from in vitro experiments can be carried out against a panel (probably two or three) of housekeeping genes whose expression has been shown to be unaffected by experimental conditions. This information must be included in any publication. Refer to MIQE guideline 5th edition published in January 2022. <a href="http://www.econferences.de/miqe-talks/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.econferences.de/miqe-talks/</a></p><p>9. Line 194: What software was used to run the statistical analyses? Please report the software, version, company, city and country that developed.</p><p>10. Number of replicates was unclear in all assays used. Under the figure, it was mentioned three independent experiments were conducted. But the number of replicates in each experiment was unclear.</p><p>Results</p><p>1. Figure 2: What is the indicator for &#x02018;A&#x02019;? Abbreviations were not provided: SnMP, MTS.</p><p>2. Line 252 &#x02013; 254; line 356 - 359 should be in the discussion rather than results.</p><p>3. Figure 3D: The * is missing. What is the indication of the black colour bars vs white and grey bars? From the previous figure (Fig. 2), black bars indicate treatment with LPZ.</p><p>4. Line 288: &#x02018;Fig. 4D&#x02026;&#x02019; There is no section D in Figure 4.</p><p>5. Figure 4 is not cited in the text.</p><p>6. Line 331: &#x02018;Nuclear fractions of the lansoprazole-treated cells were incubated in the presence or absence of &#x003bb;PPase&#x02026;. (Fig. 5A)&#x02019;. The figure is incorrectly cited in the text. It should be Fig. 4A. Same for Fig. 5B (line 361), it should be Figure 4B.</p><p>7. Legend of Figure 5. The description for (B) and (C) has been wrongly presented. Please revise accordingly.</p><p>Discussion:</p><p>1. To include more limitations of the study.</p><p>2. To include the future applications or research direction of this study.</p><p>**********</p><p>6. PLOS authors have the option to publish the peer review history of their article (<a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">what does this mean?</a>). If published, this will include your full peer review and any attached files.</p><p>If you choose &#x0201c;no&#x0201d;, your identity will remain anonymous but your review may still be made public.</p><p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Privacy Policy</a>.</p><p>Reviewer #1:&#x000a0;No</p><p>Reviewer #2:&#x000a0;<strong>Yes:&#x000a0;</strong>Yow Hui Yin</p><p>**********</p><p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p><p class="p">While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool,&#x000a0;<a href="https://pacev2.apexcovantage.com/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://pacev2.apexcovantage.com/</a>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at&#x000a0;<a href="mailto:dev@null" data-email="gro.solp@serugif" class="oemail">gro.solp@serugif</a>. Please note that Supporting Information files do not need this step.</p><div class="sec suppmat" id="pone.0287788.s003"><h4>Attachment</h4><p>Submitted filename: <em class="submitted-filename">PONE-D-22-35612_reviewer report.docx</em></p><div class="sup-box half_rhythm" id="media-a.u.b.df.c"><a href="/pmc/articles/PMC10309994/bin/pone.0287788.s003.docx" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(19K, docx)</sup></div></div></div></div></div><div class="sub-navigation nav-top space small"><ul class="page-breadcrumbs inline_list small"><li><a href="#top" class="navlink">PLoS One. 2023; 18(6): e0287788. </a></li><span> » </span><li>Author response to Decision Letter 0</li></ul></div><div class="sub-content half_rhythm" id="pone.0287788.r002"><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="part1"><span class="cit-abbr"> </span><span class="cit-pub-date">2023; </span><span class="cit-vol">18</span><span class="cit-iss">(6)</span><span class="cit-flpgs">: e0287788. </span></div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 Jun 29. </span><span class="doi"><span>doi: </span><a href="//doi.org/10.1371%2Fjournal.pone.0287788.r002" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0287788.r002</a></span></div></div></div><h1 class="sub-content-title">Author response to Decision Letter 0</h1><div class="half_rhythm"><div class="togglers fm-copyright-license"> <a href="#" class="pmctoggle" rid="idm140276940041888_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info half_rhythm"><div></div></div><div class="fm-article-notes half_rhythm"></div><div class="permissions half_rhythm hide" id="idm140276940041888_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">PMC Copyright notice</a> </div></div></div></div><div id="body-a.v.b" class="tsec sec"><h2 class="headless nomenu"></h2><p class="p p-first">
<em class="author-response-date">11 May 2023</em>
</p><p>Answer: We have revised our manuscript according to all of the editors&#x02019; and reviewers&#x02019; comments. The changes are highlighted in red in the revised manuscript. </p><p>Response to editors</p><p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. </p><p>Answer: Thank you for your comments. We have followed the style requirements in the revised version and made some changes. The Keywords and Author Contribution statements were deleted from the manuscript file. Furthermore, Supporting Information text has been added. </p><p>2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. </p><p>Answer: We have confirmed that all data underlying the findings described in our manuscript are fully available without restriction and this information has been added to the cover letter. </p><p>3. Thank you for stating the following in the Acknowledgments Section of your manuscript:</p><p>&#x0201c;This work was supported in part by a Japan Society for the Promotion of Science 478 (JSPS) KAKENHI grant (grant no. 17K15963) to N. Yamagishi.&#x0201d;</p><p>We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.</p><p>Answer: We have removed the funding information from the Acknowledgements section of the manuscript and this information has been added to the cover letter. </p><p>4. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission&#x02019;s figures or Supporting Information files.</p><p>Answer: We have newly included all the original uncropped western blotting images as Supporting Information. This is also described in in the cover letter.</p><p>5. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety.</p><p>Answer: The following sentence was added to the Data Availability Statement section.</p><p>&#x0201c;All data are contained within the manuscript and/or Supporting Information files.&#x0201d;</p><p>6. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.</p><p>Answer: Thank you. The title is now uniform across all documents and on the online submission form:</p><p>&#x0201c;Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway.&#x0201d; </p><p>Response to reviewer #1</p><p>This manuscript is very interesting and poses lansoprazole as a potential therapeutic target for oxidative stress to the liver. However, the data could be presented in a more clear fashion, and the wording in some areas could be improved. </p><p>Answer: We appreciate your comments and the opportunity to clarify the important points. </p><p>In the revised manuscript, the following points have been corrected:</p><p>1. The original title was long and contained a lot of superfluous information; we have revised it to be shorter and more concise.</p><p>2. We misquoted the figures in the original manuscript, which were confusing and difficult to understand. In the revised manuscript, we carefully checked and correctly cited the figures.</p><p>3. We have revised the wording of sentences throughout the manuscript with the help of a native speaker of English. Moreover, the Methods and Results have been described more precisely. Furthermore, all data referenced in the manuscript and the original uncropped and unadjusted images underlying all blot or gel results have been added to the Supporting Information section. </p><p>4. To strengthen the study, in addition to &#x003b2;-actin, normalization by GAPDH gene expression has been performed in all quantitative RT-PCR experiments. We added the results of quantitative RT-PCR normalized by GAPDH to Figure 1D, Figure 3B, Figure 3D, and Figure 5D. The conclusions of the experiments did not differ with either normalization, suggesting more strongly that lansoprazole induces Nrf2 downstream genes.</p><p>5. We revised the limitations of our study. In addition to the two points (&#x02171; and &#x02173; shown below) listed in the original manuscript, we have added the five limitations to the Discussion section for a total of seven limitations. </p><p>i. The assay was only performed at the third h after lansoprazole administration, so it is possible that there may be peaks in expression or function at other time points. (Lines 465 - 467)</p><p>ii. Our study could not demonstrate whether the p38 MAPK directly phosphorylates the Nrf2 in lansoprazole-treated cells. Further studies are required to define the direct association between p38 MAPK and Nrf2. (Lines 483 - 484)</p><p>iii. The series of experiments were performed in only one cell line. Lansoprazole exclusively activated p38 MAPK in RL34 cells, other MAPK signaling pathways may be activated in other cell types (e.g., human). (Lines 488 - 489)</p><p>iv. This study did not detect a direct modification of the Keap1 protein by lansoprazole. Further studies are required to demonstrate whether the hepatoprotective effect of lansoprazole results from a direct inactivation of Keap1 or from the regulation of the Keap1 inactivation by other upstream factors. (Lines 502 - 506) </p><p>v. One point that was not examined is whether the metabolites of lansoprazole are involved in the antioxidant effect. Lansoprazole is metabolized mainly in the liver to 5'-hydroxylansoprazole and lansoprazole sulfone. If these CYP molecular species are expressed in the RL34 hepatocyte cell line used in this study, the metabolites of lansoprazole may contribute to the antioxidant effect. (Lines 512 - 515)</p><p>vi. The lansoprazole concentrations used in our study were higher than those the serum concentrations clinically used. The usual dose of lansoprazole is determined by the level of gastric acid suppression; data on the optimal dose in in vivo studies of Nrf2-mediated hepatoprotective activity is currently insufficient. (Lines 516 - 518)</p><p>vii. Importantly, this study only analyzed the expression levels of HO1, NQO1, and GSTA2, which are downstream genes of Nrf2. Lansoprazole has been reported to have anti-inflammatory effects, but the expression levels of inflammatory cytokines were not investigated in this study. (Lines 525 - 528)</p><p>6. We have added the following information about future applications and research directions. </p><p>Lines 427 - 429: </p><p>&#x0201c;Lansoprazole is one of the most prescribed drugs worldwide, and consequently has well-established safety and efficacy. Therefore, lansoprazole is expected to expand its clinical application relatively quickly in the future as a treatment for liver diseases.&#x0201d;</p><p>&#x03000;</p><p>Lines 536 - 542:</p><p>&#x0201c;Oxidative stress is the cause of most liver diseases, and it is a plausible therapeutic target to prevent liver damage [58]. The induction of the antioxidant Nrf2 pathway may protect hepatic cells from oxidative stress and avoid the progression of disease. Various compounds have been postulated to increase Nrf2 activity, although an effective Nrf2 inducer is not currently available to counteract liver diseases. This study extended prior knowledge on the acid-independent effect of lansoprazole and provided novel insights into the mechanisms involved. Thus, lansoprazole may be a potential candidate for the treatment of liver diseases. &#x0201d;</p><p>Response to reviewer #2:</p><p>Overview:</p><p>Generally, the manuscript presented the novelty of the study in elucidating the potential molecular mechanisms of lansoprazole in cisplatin-induced hepatoxicity in rat hepatic RL34 cells. This manuscript provides an insightful scientific impact on the molecular mechanisms of lansoprazole. The study design and method used were reliable, yet the reporting in methods and results require improvements.</p><p>Strengths:</p><p>1. This paper presented novel insights on the mechanisms of lansoprazole.</p><p>2. The method used was robust and reliable.</p><p>Limitations:</p><p>1. Poor reporting in methodology and result.</p><p>2. Gene expression study with 1 housekeeping gene is less convincing.</p><p>Answer: We appreciate your comments and the opportunity to clarify this important point. We have changed as detailed below.</p><p>Title: Title is too length with too many unnecessary words. Suggest to revise.</p><p>Answer: Thank you for your suggestions. We have shortened the title to the minimum number of characters required as follows:</p><p>&#x0201c;Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway.&#x0201d; </p><p>Abstract:</p><p>1. Lines 14; 28: Kindly avoid the use of first- and second-person pronouns (i.e. we) in the abstract. Please use active voice and third-person narrative throughout the manuscript.</p><p>Answer: The first- and second-person pronouns have been revised in the abstract as appropriate, and we have striven to use active voice and third-person narrative in the main part of the revised manuscript. </p><p>2. Line 20: Typo for &#x02018;NAD(P)H:1quinone oxidoreductase-1&#x02019;? It should be written as &#x02018;NAD(P)H quinone oxidoreductase-1&#x02019;.</p><p>Answer: As you indicated, this was incorrect and has been corrected. </p><p>3. Method was not mentioned in the abstract.</p><p>Answer: We added the following information regarding the methodology to lines 17 - 21 of the revised manuscript abstract: </p><p>&#x0201c;Herein, we sought to investigate the molecular mechanism of cytoprotection by lansoprazole. An in vitro experimental model was conducted using cultured rat hepatic cells treated with lansoprazole to analyze the expression levels of Nrf2 and its downstream genes, the activity of Nrf2 using luciferase reporter assays, cisplatin-induced cytotoxicity, and signaling pathways involved in Nrf2 activation.&#x0201d;</p><p>Introduction</p><p>1. Line 48: &#x02018;The nuclear Nrf2&#x02026;&#x02019;</p><p>Answer: Please provide further details on what requires correction. We are unsure what you mean here. </p><p>2. Lines 72 - 79: Kindly avoid the use of first- and second-person pronouns (i.e. we) in the abstract. Please use active voice and third-person narrative.</p><p>Answer: The first- and second-person pronouns have been corrected into third-person in the abstract as specified.</p><p>3. Suggest to include the relationship of nrf-2 with p38 and Erk1 in introduction to provide an better overview on the signaling pathway involved and further justified on the choice of antibodies used in Western blotting.</p><p>Answer: The relationship between Nrf-2, p38, and Erk1 is described, and the signaling pathway is outlined in lines 54 - 57 of the Introduction section of the revised manuscript as follows:</p><p>&#x0201c;Mitogen-activated protein kinase (MAPK) signaling pathways play important roles in the modulation of ARE-driven gene expression via Nrf2 activation [12-14]. Herein, the capability of lansoprazole to upregulate expression of antioxidant genes via the MAPK/ARE/Nrf2 pathway was investigated using rat hepatic cells.&#x0201d;</p><p>Methods</p><p>1. Some chemicals or materials only provided with brand name without the city and country of manufacturing, including FBS, DMSO, DMEM, MTS reagent, lansoprazole, RIPA buffer, hygromycin, luciferase assay, anti-rabbit IgG antibody.</p><p>Answer: We have added the name of the city and the country of manufacture throughout the Chemicals and Reagents section as specified. </p><p>2. How many replicates run in cell viability assay (MTS)? How many sets of experiment samples per replicate? Please mention in the method.</p><p>Answer: Thank you for pointing that out. The cell viability assay (MTS) was performed in three independent experiments, each performed in triplicate. This information has been added to lines 110 - 111 of the method in the revised manuscript as follows: </p><p>&#x0201c;Data for cell viability represent the results of at least three independent experiments, each experiment was performed in triplicate.&#x0201d;</p><p>3. Line 106: What 96-well plate reader was used? Please specify the brand of equipment along with the city and country.</p><p>Answer: We used a 96-well plate reader manufactured by Corona Electric Co., Ltd. (Ibaraki, Japan). This detail has been added to line 109 of the Methods section in the revised manuscript. </p><p>4. Line 134: CHX abbreviation was used without providing the full term when it was first introduced in the text.</p><p>Answer: The full term for CHX (Cycloheximide) is now shown on line 87 of the Methods section in the revised manuscript. </p><p>5. Line 140: Version, city and country of ImageJ?</p><p>Answer: The version of Imagej and the names of the city and country have been added to line 146-147 of the revised manuscript as follows: </p><p>&#x0201c;ImageJ ver. 1.53v 21 (U.S. National Institutes of Health, Bethesda, Maryland, USA).&#x0201d;</p><p>6. Line 151: The amount of total RNA used to reverse-transcribed into cDNA was not mentioned.</p><p>Answer: We used 200 ng of total RNA to create cDNA for all quantitative RT-PCRs. This information has been added to line 159 of the revised manuscript.</p><p>7. The experiment setting for gene expression in PCR assay was unclear: volume of reaction mix of PCR, thermal cycling condition, number of replicates, negative control, the validation or optimization of primers, etc.</p><p>Answer: Detailed information on PCR assay conditions has been added to lines 159 - 176 of the revised manuscript as follows:</p><p>&#x0201c;First strand cDNA was synthesized with the use of the ReverTra Ace qPCR RT Kit (Toyobo, Osaka, Japan) following the manufacturer's instructions in a final volume of 20 &#x003bc;l. The final cDNA fragments were diluted 10-fold before use in RT-PCR. Quantitative RT-PCR analyses were performed using the Brilliant III Ultra-Fast SYBR Green QPCR Master Mix (Agilent Technologies Inc., Tokyo, Japan) and the AriaMX Real-time PCR system (Agilent Technologies Inc.). Each reaction contained 2.5 &#x003bc;L 10-fold diluted cDNA, 200 nM of each primer, and 1 &#x000d7; SYBR Green Master Mix, in a final volume of 10 &#x003bc;L. All reactions were performed in duplicate per cDNA sample. As a control for genomic DNA contamination, total RNA without reverse transcription was tested for each sample per gene. A no-template control was included in each run per gene. The thermal profile of the reaction was 95&#x000b0;C for 5 min activation and denaturation, followed by 40 cycles of 95&#x000b0;C for 10 sec, and 60&#x000b0;C for 10 sec. Finally, a melting curve was generated by increasing temperature starting from 65&#x000b0;C to 95&#x000b0;C to determine the specificity of the reactions. The quantification cycle number (Cq) was determined per reaction with Agilent AriaMx version 2.0. The primers used are listed in Table 1. The relative standard curve method was used to calculate the relative mRNA expression. mRNA expression levels were normalized to those of &#x003b2;-actin and glyceraldehyde-triphosphate dehydrogenase (GAPDH) mRNA. Data represent the results of three independent experiments, and each experiment was performed in triplicate.&#x0201d;</p><p>8. Line 157: Only one housekeeping gene was used (beta actin), which is insufficient and at least two housekeeping genes are require for in vitro experiments. Based on MIQE guideline for qPCR, normalization of samples obtained from in vitro experiments can be carried out against a panel (probably two or three) of housekeeping genes whose expression has been shown to be unaffected by experimental conditions. This information must be included in any publication. Refer to MIQE guideline 5th edition published in January 2022. <a href="http://www.econferences.de/miqe-talks/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.econferences.de/miqe-talks/</a></p><p>Answer: As a suggestion, in addition to &#x003b2;-actin, normalization by GAPDH gene expression was performed. We have added content to line 175 of the Methods section in the revised manuscript, and the results of quantitative RT-PCR normalized by GAPDH were added to Fig.1D, Fig.3B, Fig.3D, and Fig.5D. There was no difference to the conclusions of the experiment with either normalization. </p><p>9. Line 194: What software was used to run the statistical analyses? Please report the software, version, company, city and country that developed.</p><p>Answer: All statistical analyses were performed using JMP version 14.3 statistical software (SAS Institute Inc., Cary, NC, USA). This information has been added to line 214 of the revised manuscript.</p><p>10. Number of replicates was unclear in all assays used. Under the figure, it was mentioned three independent experiments were conducted. But the number of replicates in each experiment was unclear.</p><p>Answer: All experiments were performed in triplicate, and this detail has been added to each figure legend. </p><p>Results</p><p>1. Figure 2: What is the indicator for &#x02018;A&#x02019;? Abbreviations were not provided: SnMP, MTS.</p><p>Answer: Figure 2 is composed of a single figure, so "A" has been removed, and the full terms SnMP and MTS have been added to the legend of Figure 2 (lines 286 - 288 of the revised manuscript).</p><p>2. Lines 252 &#x02013; 254; lines 356 - 359 should be in the discussion rather than results.</p><p>Answer: As the reviewer pointed out, we have moved lines 252-254 to lines 437 - 441 in the Discussion section of the revised manuscript as follows. </p><p>&#x0201c;Cisplatin is a commonly utilized chemotherapeutic agent, and confers toxicity to various tissues, including the liver. Growing evidence indicates that the production of ROS induced by cisplatin can trigger oxidative stress, and even cause cell death [16-18, 38, 39]. Increased oxidative stress is one of the main mechanisms involved in cisplatin-induced hepatotoxicity, as indicated by both in vitro and in vivo studies [18].&#x0201d;</p><p>Furthermore, we have removed lines 356 &#x02013; 359 because the same description appears in lines 488- 492 of the Discussion section.</p><p>3. Figure 3D: The * is missing. What is the indication of the black colour bars vs white and grey bars? From the previous figure (Fig. 2), black bars indicate treatment with LPZ.</p><p>Answer: Thank you for the careful review. We have added the * to the revised Figure 3F (Figure 3D in the original manuscript). There was confusing representation of the color of the bar in Figure 3. In the revised version, we have unified the bars for untreated samples to white and the bars for treated samples to black through the entire figure. </p><p>4. Line 288: &#x02018;Fig. 4D&#x02026;&#x02019; There is no section D in Figure 4.</p><p>Answer: Apologies. We made a big mistake about Figure 4. Fig. 4D in the original manuscript has been corrected to Fig. 3F in the revised version. </p><p>5. Figure 4 is not cited in the text.</p><p>Answer: Thank you for pointing this out. In the revised manuscript, Figure 4A is now cited on line 340 and Figure 4B is cited on line 344. Figure 5 is cited in the correct position on lines 367 - 371.</p><p>6. Line 331: &#x02018;Nuclear fractions of the lansoprazole-treated cells were incubated in the presence or absence of &#x003bb;PPase&#x02026;. (Fig. 5A)&#x02019;. The figure is incorrectly cited in the text. It should be Fig. 4A. Same for Fig. 5B (line 361), it should be Figure 4B.</p><p>Answer: Thank you for pointing this out. As indicated in the comment #5 above, we have corrected the mistakes. </p><p>7. Legend of Figure 5. The description for (B) and (C) has been wrongly presented. Please revise accordingly.</p><p>Answer: We have corrected the legend of Figure 5. </p><p>Discussion:</p><p>1. To include more limitations of the study.</p><p>Answer: Thank you for your suggestions. In addition to the two points (second and fourth shown below) in the original version of the manuscript, we have added five limitations of this study to the Discussion section, for a total seven limitation, which are listed below. </p><p>Lines 465- 467: </p><p>&#x0201c;One limitation of this study, based on previous reports [32], is that sampling was conducted at 3 h after lansoprazole treatment, and stronger antioxidant activity could be observed if tested with a longer time course.&#x0201d;</p><p>Lines 483- 485: </p><p>&#x0201c;However, as a second limitation, our study could not demonstrate whether the p38 MAPK directly phosphorylates the Nrf2 in lansoprazole-treated cells. Further studies are required to define the direct association between p38 MAPK and Nrf2.&#x0201d;</p><p>Lines 488- 491: </p><p>&#x0201c;A third limitation is that the experiments were performed in only one cell line. Although lansoprazole caused exclusive p38 MAPK activation in RL34 cells, it is possible that other MAPK signaling pathways are activated in other cell types (e.g., human).&#x0201d;</p><p>Lines 502- 506:</p><p>&#x0201c;However, as a fourth limitation, this study did not detect a direct modification of the Keap1 protein by lansoprazole. Further studies are required to demonstrate whether the hepatoprotective effect of lansoprazole results from a direct inactivation of Keap1 or from the regulation of the Keap1 inactivation by other upstream factors.&#x0201d;&#x03000;</p><p>Lines 512- 515: </p><p>&#x0201c;As a fifth limitation, the present study could not determine whether the cytoprotective effect of lansoprazole was caused by acid-induced activation or metabolism by CYP emzymes, and this requires future investigation.&#x0201d;</p><p>Lines 516 - 518:</p><p>&#x0201c;The concentration of 100 &#x003bc;M lansorazole employed in this study is much higher than the maximum serum concentration in healthy adults given a single oral administration of 30 mg lansoprazole, which corresponds a sixth limitation.&#x0201d;</p><p>Lines 525 - 528:</p><p>&#x0201c;As a seventh limitation, lansoprazole is reported to have anti-inflammatory effects [19, 20], but the expression levels of inflammatory cytokines were not investigated in this study. Therefore, subsequent studies should focus on inflammatory cytokines and investigate gene expression levels, focusing on those downstream of Nrf2.&#x0201d;</p><p>2. To include the future applications or research direction of this study.</p><p>Answer: Thank you for your suggestion. Based on this study, we have added the following to the Discussion section for future applications and research directions for lansoprazole. </p><p>Lines 427- 429:</p><p>&#x0201c;Lansoprazole is one of the most prescribed drugs worldwide, and consequently has well-established safety and efficacy. Therefore, lansoprazole is expected to expand its clinical application relatively quickly in the future as a treatment for liver diseases.&#x0201d;&#x03000;</p><p>Lines 536- 542: </p><p class="p">&#x0201c;Oxidative stress is the cause of most liver diseases, and it is a plausible therapeutic target to prevent liver damage [58]. The induction of the antioxidant Nrf2 pathway may protect hepatic cells from oxidative stress and avoid the progression of disease. Various compounds have been postulated to increase Nrf2 activity, although an effective Nrf2 inducer is not currently available to counteract liver diseases. This study extended prior knowledge on the acid-independent effect of lansoprazole and provided novel insights into the mechanisms involved. Thus, lansoprazole may be a potential candidate for the treatment of liver diseases.&#x0201d;</p><div class="sec suppmat" id="pone.0287788.s004"><h4>Attachment</h4><p>Submitted filename: <em class="submitted-filename">Response to Reviewers.docx</em></p><div class="sup-box half_rhythm" id="media-a.v.b.ee.c"><a href="/pmc/articles/PMC10309994/bin/pone.0287788.s004.docx" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(37K, docx)</sup></div></div></div></div></div><div class="sub-navigation nav-top space small"><ul class="page-breadcrumbs inline_list small"><li><a href="#top" class="navlink">PLoS One. 2023; 18(6): e0287788. </a></li><span> » </span><li>Decision Letter 1</li></ul></div><div class="sub-content half_rhythm" id="pone.0287788.r003"><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="part1"><span class="cit-abbr"> </span><span class="cit-pub-date">2023; </span><span class="cit-vol">18</span><span class="cit-iss">(6)</span><span class="cit-flpgs">: e0287788. </span></div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 Jun 29. </span><span class="doi"><span>doi: </span><a href="//doi.org/10.1371%2Fjournal.pone.0287788.r003" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0287788.r003</a></span></div></div></div><h1 class="sub-content-title">Decision Letter 1</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yap%20WH%5BAuthor%5D">Wei Hsum Yap</a>, <span class="fm-role">Academic Editor</span></div><div style="display:none" class="contrib-group aff-tip"></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"> <a href="#" class="pmctoggle" rid="idm140276939974816_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info half_rhythm"><div></div></div><div class="fm-article-notes half_rhythm"></div><div class="permissions half_rhythm hide" id="idm140276939974816_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2023 Wei Hsum Yap</div><div class="fm-copyright half_rhythm">This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</div></div></div></div><div id="body-a.w.b" class="tsec sec"><h2 class="headless nomenu"></h2><p class="p p-first">
<em class="letter-date">17 May 2023</em>
</p><p>PONE-D-22-35612R1Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathwayPLOS ONE</p><p>Dear Dr. Yamagishi,</p><p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE&#x02019;s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p><p>Please submit your revised manuscript by Jul 01 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at&#x000a0;<a href="mailto:dev@null" data-email="gro.solp@enosolp" class="oemail">gro.solp@enosolp</a>. When you're ready to submit your revision, log on to <a href="https://www.editorialmanager.com/pone/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://www.editorialmanager.com/pone/</a> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p><p>Please include the following items when submitting your revised manuscript:</p><ul class="unordered" style="list-style-type:disc"><li><div>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</div></li><li><div>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</div></li><li><div>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</div></li></ul><p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p><p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <a href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</a>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <a href="https://plos.org/protocols?utm_medium=editorial-email&#x00026;utm_source=authorletters&#x00026;utm_campaign=protocols" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://plos.org/protocols?utm_medium=editorial-email&#x00026;utm_source=authorletters&#x00026;utm_campaign=protocols</a>.</p><p>We look forward to receiving your revised manuscript.</p><p>Kind regards,</p><p>Wei Hsum Yap</p><p>Academic Editor</p><p>PLOS ONE</p><p>Journal Requirements:</p><p>Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article&#x02019;s retracted status in the References list and also include a citation and full reference for the retraction notice.</p><p>Additional Editor Comments:</p><p>Dear authors, please include the following revisions:</p><p>1. There is no explanation for relationship between Nrf2, p38 and ERK1 in Introduction section Line 53-57. Please include justification on why these kinases are included in the current study.</p><p>2. Please include the final concentration or quantity of cDNA that was used in the reaction (Line 161-162)</p><p>3. Please include CHX abbreviations in Fig 1 caption - each diagram is independent, and should include info for abbreviated text within the image</p><p>4. Please change "single administration of" (Line 330) to cisplatin treatment group</p><p>5. Line 336-337 the sentence is ambiguous because Fig 1A is showing Western blot analysis instead of SDS-PAGE. Suggest rephrasing or removing the sentence to provide a better flow of explanation.</p><p>[Note: HTML markup is below. Please do not edit.]</p><p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p><p class="p p-last">While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool,&#x000a0;<a href="https://pacev2.apexcovantage.com/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://pacev2.apexcovantage.com/</a>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at&#x000a0;<a href="mailto:dev@null" data-email="gro.solp@serugif" class="oemail">gro.solp@serugif</a>. Please note that Supporting Information files do not need this step.</p></div></div></div><div class="sub-navigation nav-top space small"><ul class="page-breadcrumbs inline_list small"><li><a href="#top" class="navlink">PLoS One. 2023; 18(6): e0287788. </a></li><span> » </span><li>Author response to Decision Letter 1</li></ul></div><div class="sub-content half_rhythm" id="pone.0287788.r004"><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="part1"><span class="cit-abbr"> </span><span class="cit-pub-date">2023; </span><span class="cit-vol">18</span><span class="cit-iss">(6)</span><span class="cit-flpgs">: e0287788. </span></div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 Jun 29. </span><span class="doi"><span>doi: </span><a href="//doi.org/10.1371%2Fjournal.pone.0287788.r004" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0287788.r004</a></span></div></div></div><h1 class="sub-content-title">Author response to Decision Letter 1</h1><div class="half_rhythm"><div class="togglers fm-copyright-license"> <a href="#" class="pmctoggle" rid="idm140276939947520_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info half_rhythm"><div></div></div><div class="fm-article-notes half_rhythm"></div><div class="permissions half_rhythm hide" id="idm140276939947520_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">PMC Copyright notice</a> </div></div></div></div><div id="body-a.x.b" class="tsec sec"><h2 class="headless nomenu"></h2><p class="p p-first">
<em class="author-response-date">8 Jun 2023</em>
</p><p>Journal requirements: </p><p>Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article&#x02019;s retracted status in the References list and also include a citation and full reference for the retraction notice.</p><p>Answer: We have carefully reviewed the references list and properly revised it, and we have ensured its correctness and completeness. </p><p>Additional Editor Comments:</p><p>Dear authors, please include the following revisions:</p><p>1. There is no explanation for relationship between Nrf2, p38 and ERK1 in Introduction section Line 53-57. Please include justification on why these kinases are included in the current study. </p><p>Answer: We appreciate your comments and the opportunity to clarify these important points. The relationship between Nrf2 and MAPKs is described in lines 56 - 74 of the revised manuscript as follows: </p><p>&#x0201c;Exposure of cells to Nrf2 inducers, like oxidative stress stimuli, activates Nrf2/ARE-mediated response through different intracellular signaling pathways. Mitogen-activated protein kinase (MAPK) pathways are known to regulate Nrf2/ARE-driven gene expression [12-14]. MAPKs are serine/threonine protein kinase that play a central role in the signaling cascade regulating cellular processes, such as cell proliferation, differentiation, and apoptosis. Three major MAPK subfamilies have been extensively studied: extracellular signal-regulated kinases (ERKs), c-Jun N-terminal kinases (JNKs), and p38 MAPK. Each kinase establishes, in principle, parallel and independent signaling pathways. Depending on the cellular and stimulatory context, there is often significant cross-talk between each of the kinases because they can respond to common upstream activators and phosphorylate common downstream targets. Alam et al. reported that cadmium-induced HO1 gene expression requires the sequential activation of the p38 MAPK pathway and Nrf2 in human breast cancer MCF-7 cells [12]. In contrast, in human hepatoblastoma HepG2 cells, JNK activated the induction of Nrf2/ARE-mediated gene expression by the overexpression of common upstream kinases, whereas p38 MAPK showed the opposite effects [13]. Additionally, exposure of HepG2 cells to the chemical pyrrolidine dithiocarbamate, the activation of both ERK1/2 and p38 MAPK are required for induction of the ARE-mediated &#x003b3;-glutamylcysteine synthetase subunit genes [14]. Based on these observations, the capability of lansoprazole to upregulate expression of antioxidant genes via the MAPK/ARE/Nrf2 pathway was investigated using rat hepatic cells.&#x0201d;</p><p>2. Please include the final concentration or quantity of cDNA that was used in the reaction (Line 161-162)</p><p>Answer: We used 2.5 &#x003bc;l per well (2.5 ng/reaction) of 10-fold diluted cDNA solution for all quantitative RT-PCR. This information has been added to lines 180 and 183 of the revised manuscript.</p><p>3. Please include CHX abbreviations in Fig 1 caption - each diagram is independent, and should include info for abbreviated text within the image</p><p>Answer: We have added the abbreviation for CHX to Fig. 1 caption (Lines 283 - 284 of the revised manuscript). </p><p>4. Please change "single administration of" (Line 330) to cisplatin treatment group</p><p>Answer: We have changed this to &#x0201c;cisplatin treatment group&#x0201d; (Line 352 of the revised manuscript). </p><p>5. Line 336-337 the sentence is ambiguous because Fig 1A is showing Western blot analysis instead of SDS-PAGE. Suggest rephrasing or removing the sentence to provide a better flow of explanation.</p><p>Answer: Thank you for pointing this out. In the revised manuscript, lines 357 - 359 have been changed as follows:</p><p class="p">&#x0201c;The Nrf2 band was found to be upshifted in the nuclear fraction of the lansoprazole-treated cells (Fig. 1A) indicating that Nrf2 translocated to the nucleus underwent posttranscriptional modifications.&#x0201d;</p><div class="sec suppmat" id="pone.0287788.s005"><h4>Attachment</h4><p>Submitted filename: <em class="submitted-filename">Response to Reviewers.docx</em></p><div class="sup-box half_rhythm" id="media-a.x.b.s.c"><a href="/pmc/articles/PMC10309994/bin/pone.0287788.s005.docx" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(41K, docx)</sup></div></div></div></div></div><div class="sub-navigation nav-top space small"><ul class="page-breadcrumbs inline_list small"><li><a href="#top" class="navlink">PLoS One. 2023; 18(6): e0287788. </a></li><span> » </span><li>Decision Letter 2</li></ul></div><div class="sub-content half_rhythm" id="pone.0287788.r005"><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="part1"><span class="cit-abbr"> </span><span class="cit-pub-date">2023; </span><span class="cit-vol">18</span><span class="cit-iss">(6)</span><span class="cit-flpgs">: e0287788. </span></div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 Jun 29. </span><span class="doi"><span>doi: </span><a href="//doi.org/10.1371%2Fjournal.pone.0287788.r005" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0287788.r005</a></span></div></div></div><h1 class="sub-content-title">Decision Letter 2</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yap%20WH%5BAuthor%5D">Wei Hsum Yap</a>, <span class="fm-role">Academic Editor</span></div><div style="display:none" class="contrib-group aff-tip"></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"> <a href="#" class="pmctoggle" rid="idm140276939930928_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info half_rhythm"><div></div></div><div class="fm-article-notes half_rhythm"></div><div class="permissions half_rhythm hide" id="idm140276939930928_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2023 Wei Hsum Yap</div><div class="fm-copyright half_rhythm">This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</div></div></div></div><div id="body-a.y.b" class="tsec sec"><h2 class="headless nomenu"></h2><p class="p p-first">
<em class="letter-date">13 Jun 2023</em>
</p><p>Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway</p><p>PONE-D-22-35612R2</p><p>Dear Dr. Yamagishi,</p><p>We&#x02019;re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p><p>Within one week, you&#x02019;ll receive an e-mail detailing the required amendments. When these have been addressed, you&#x02019;ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p><p>An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <a href="http://www.editorialmanager.com/pone/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.editorialmanager.com/pone/</a>, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <a href="mailto:dev@null" data-email="gro.solp@gnillibrohtua" class="oemail">gro.solp@gnillibrohtua</a>.</p><p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they&#x02019;ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <a href="mailto:dev@null" data-email="gro.solp@sserpeno" class="oemail">gro.solp@sserpeno</a>.</p><p>Kind regards,</p><p>Wei Hsum Yap</p><p>Academic Editor</p><p>PLOS ONE</p><p>Additional Editor Comments (optional):</p><p class="p p-last">Reviewers' comments:</p></div></div></div><div class="sub-navigation nav-top space small"><ul class="page-breadcrumbs inline_list small"><li><a href="#top" class="navlink">PLoS One. 2023; 18(6): e0287788. </a></li><span> » </span><li>Acceptance letter</li></ul></div><div class="sub-content half_rhythm" id="pone.0287788.r006"><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="part1"><span class="cit-abbr"> </span><span class="cit-pub-date">2023; </span><span class="cit-vol">18</span><span class="cit-iss">(6)</span><span class="cit-flpgs">: e0287788. </span></div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 Jun 29. </span><span class="doi"><span>doi: </span><a href="//doi.org/10.1371%2Fjournal.pone.0287788.r006" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0287788.r006</a></span></div></div></div><h1 class="sub-content-title">Acceptance letter</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yap%20WH%5BAuthor%5D">Wei Hsum Yap</a>, <span class="fm-role">Academic Editor</span></div><div style="display:none" class="contrib-group aff-tip"></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"> <a href="#" class="pmctoggle" rid="idm140276939914976_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info half_rhythm"><div></div></div><div class="fm-article-notes half_rhythm"></div><div class="permissions half_rhythm hide" id="idm140276939914976_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2023 Wei Hsum Yap</div><div class="fm-copyright half_rhythm">This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10309994&amp;issue-id=437135&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</div></div></div></div><div id="body-a.z.b" class="tsec sec"><h2 class="headless nomenu"></h2><p class="p p-first">
<em class="letter-date">22 Jun 2023</em>
</p><p>PONE-D-22-35612R2 </p><p>Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway </p><p>Dear Dr. Yamagishi:</p><p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. </p><p>If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <a href="mailto:dev@null" data-email="gro.solp@sserpeno" class="oemail">gro.solp@sserpeno</a>.</p><p>If we can help with anything else, please email us at <a href="mailto:dev@null" data-email="gro.solp@enosolp" class="oemail">gro.solp@enosolp</a>. </p><p>Thank you for submitting your work to PLOS ONE and supporting open access. </p><p>Kind regards, </p><p>PLOS ONE Editorial Office Staff</p><p>on behalf of</p><p>Dr. Wei Hsum Yap </p><p>Academic Editor</p><p class="p p-last">PLOS ONE</p></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">PLOS ONE</span> are provided here courtesy of <strong>PLOS</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10309994/pdf/pone.0287788.pdf" class="int-view">PDF (2.3M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10309994/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10309994/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10309994" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10309994%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="X2YLHuY8I65Nk6DgSg5M9YTZR1Rf2OEOyqCOv8rQTY8jDPAhoFr3H4UfA84JTgyB">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10309994%2F&amp;text=Lansoprazole%20protects%20hepatic%20cells%20against%20cisplatin-induced%20oxidative%20stress%20through%20the%20p38%20MAPK%2FARE%2FNrf2%20pathway%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10309994%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309994/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10309994/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37384717/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10309994/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37384717/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10309994/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10309994/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC10309994/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
